SAN FRANCISCO, March 27, 2026 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against China’s largest online travel agency, Trip.com Group (NASDAQ: TCOM), seeking to represent investors who purchased Trip.com securities between April 30, 2024 and January 13, 2026.
The lawsuit follows the 17% decline in the price of Trip.com American Depositary Shares on January 14, 2026. The selloff, which wiped out billions of dollars of the company’s market capitalization, was triggered by the company’s announcement that it is the subject of an investigation by regulators in China pursuant to the Anti-Monopoly Law of the People’s Republic of China.
The development and severe market reaction have prompted national shareholders rights firm Hagens Berman to commence an investigation into whether Trip.com violated the federal securities laws, as alleged in the complaint.
The firm urges investors in Trip.com American Depository Shares who suffered significant losses to submit your losses now.
Class Period: Apr. 30, 2024 – Jan. 13, 2026
Lead Plaintiff Deadline: May 11, 2026
Visit: www.hbsslaw.com/investor-fraud/tcom
Contact the Firm Now: [email protected] | 844-916-0895
Trip.com Group Limited (TCOM) Securities Class Action:
In the past, Trip.com repeatedly touted its AI price adjustment tool, calling its AI approach “a cornerstone of our long-term strategy” and assured investors that its disclosure controls and procedures were effective. The company’s price adjustment tool automatically lowers hotel rates on its platform when detecting higher prices elsewhere.
The complaint alleges that these and other assurances misled investors because Trip.com materially understated the regulatory risk the company faced for its monopolistic business conduct.
Investors began to learn the truth by late November 2025, when the financial press reported that hotel merchants partnering with Trip.com reported losing pricing autonomy under the company’s platform. In addition, regulators scrutinizing the company reportedly identified the price adjustment tool as enabling Trip.com to force participation in promotions, undercut competitors, and penalize non-compliant merchants with reduced visibility or delisting.
Then, on January 14, 2026, Trip.com revealed it “received a notice of investigation from the State of Administration for Market Regulations of the People’s Republic of China (the ‘SAMR’)[]” and “the SAMR has commenced an investigation involving the Company pursuant to the Anti-Monopoly Law of the People’s Republic of China.”
The market reacted swiftly, sending the price of Trip.com American Depositary Shares down $12.90 (-17%), wiping out over $8 billion of market capitalization in a single day.
After the Class Period, on February 26, 2026, Trip.com announced with no explanation that its co-founders abruptly resigned from the company’s board, effective the day before.
Then, on March 8, 2026, pandaily reported that “Trip.com will shut down its automated hotel AI price adjustment tool on March 10, aiming to curb price wars and restore pricing autonomy for hotel partners.” In addition, the article said “[s]everal hotel partners claimed the system automatically scanned competitors’ prices and forced price reductions on their own listings, a practice some describe as ‘one-sided coercion.’”
“We’re investigating whether Trip.com may have misled investors about the true purpose of its AI pricing tool and the sustainability of its business model without it,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.
If you invested in Trip.com American Depository Shares and have substantial losses, or have knowledge that may assist the firm’s investigation, SUBMIT YOUR TCOM ADS LOSSES NOW.
If you’d like more information and answers to additional frequently asked questions about the Trip.com case and the firm’s investigation, read more.
Whistleblowers: Persons with non-public information regarding Trip.com should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Contact:
Reed Kathrein, 844-916-0895
2026-03-27 17:451mo ago
2026-03-27 13:411mo ago
ACN Continues to Focus on AI Development: Is it a Growth Catalyst?
Key Takeaways Accenture invests in DaVinci Commerce, partnering via Song to shift brands to AI-driven commerce models.Accenture and Anthropic launch Cyber.AI to enable faster, automated cybersecurity amid rising AI risks.Accenture expands Microsoft tie-up, enhancing MxDR with analytics and autonomous threat response tools. In a bid to remain technologically updated in this Artificial Intelligence (AI)-driven era, Accenture plc (ACN - Free Report) announced an investment in DaVinci Commerce, a company that specializes in agentic AI-powered commerce.
The investment has been made through Accenture Ventures and includes a strategic partnership with Accenture Song. Through the partnership, Accenture Song will work with DaVinci Commerce to help brands transition from traditional commerce models to AI-driven discovery and transactions. This enables Accenture to help clients in enhancing personalization, staying competitive and capturing new growth opportunities as agentic commerce continues to evolve.
Accenture’s investment in DaVinci Commerce underscores its focus on the emerging space of agentic AI-led shopping, where intelligent systems increasingly shape purchasing decisions.
In another AI-related development, Accenture and Anthropic’s launch of Cyber.AI reflects a meaningful shift toward AI-driven cybersecurity, enabling organizations to move from reactive, human-paced defenses to faster, automated operations.With rising AI-related cyber risks, Cyber.AI is well-positioned to help enterprises scale security operations, improve resilience and achieve more consistent outcomes.
Accenture’s expanded collaboration with Microsoft (MSFT - Free Report) reflects a push toward integrating agentic AI into cybersecurity operations to improve threat detection and response. By enhancing its MxDR platform with advanced analytics and autonomous capabilities, Accenture aims to help organizations streamline security operations, reduce complexity and respond to threats more efficiently. This partnership positions both Accenture and Microsoft to address growing concerns around cyber resilience, enabling enterprises to strengthen defenses and scale more proactive, intelligence-driven security strategies.
In another AI-related development, Microsoft alsoteamed up with NVIDIA (NVDA - Free Report) to advance AI in nuclear energy, delivering end-to-end tools designed to ease regulatory approvals, fast-track design and enhance operational efficiency. The growing demand for generative AI and large language models using graphics processing units (GPUs) based on NVIDIA’s Hopper and Blackwell architectures is aiding data center revenues. NVIDIA is rapidly gaining traction in enterprise AI, expanding its market beyond cloud providers.
ACN’s Price Performance, Valuation & EstimatesShares of Accenture have declined 20.5% over the past six months, compared with the Zacks Computers - IT Services industry’s loss of 23.9%.
Six-Month Price Comparison Image Source: Zacks Investment Research
From a valuation standpoint, ACN trades at a 12-month forward price-to-sales ratio of 1.59X, lower than industrial levels.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for full-year 2026 and 2027 earnings per share has improved in the past 90 days.
Image Source: Zacks Investment Research
ACN's Zacks RankAccenture currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Memory stocks got hammered this week after Google dropped a research paper that has investors questioning the entire thesis for the AI-driven memory bull run. Alphabet's ((GOOGL - Free Report) ) Google Research group published details on Tuesday of a new compression algorithm called TurboQuant, and the fallout was swift. Sandisk Corporation ((SNDK - Free Report) ) plunged as much as 11%, Micron Technology ((MU - Free Report) ) dropped 7% on Thursday as the selling accelerated, and Western Digital and Seagate each fell over 7%. The damage extended overseas, with Samsung and SK Hynix both sliding more than 5% in Seoul. As of this morning, the group is rebounding.
Both Micron and SanDisk currently carry a Zacks Rank #1 (Strong Buy). The supply constrained dynamic and exceptional demand for DRAM has pushed these stocks to incredible performances in the last six months, with SNDK up nearly 5x and MU more than doubling over that period.
So is Alphabet building a technology that destroys the bull case for this niche AI infrastructure boom? Or is this a case of headline-driven profit-taking in an overextended sector?
Image Source: Zacks Investment Research
What Alphabet’s TurboQuant Actually DoesAt its core, TurboQuant addresses one of the most expensive bottlenecks in running large language models: the key-value (KV) cache. This is the high-speed data store that retains context so a model doesn't have to recompute everything with each new token it generates. As models process longer inputs, the KV cache balloons, consuming GPU memory that could otherwise serve more users or run larger models.
Google's algorithm compresses the KV cache significantly, reducing its memory footprint by nearly 6x without sacrificing accuracy or requiring model retraining. Tested across five standard AI models, TurboQuant achieved perfect scores on retrieval tasks. Testing showed that it delivered up to an 8x acceleration in computing attention on Nvidia H100 GPUs.
Beyond LLMs, Alphabet noted that TurboQuant also improves vector search, the technology underpinning everything from Google Search to YouTube recommendations to ad targeting.
Memory Stocks Micron and Sandisk Sell Off SharplyThe sell-off in Micron, Sandisk, and their memory peers echoed the DeepSeek-driven panic from early 2025, when a Chinese AI lab demonstrated that competitive models could be trained with far less compute than assumed. That episode triggered a one-day massacre in semiconductor names before the market ultimately concluded that efficiency gains accelerate adoption, and adoption drives more hardware demand, not less.
The same logic may apply here. TurboQuant compresses data during inference, not training. That's an important distinction. AI model training, which is where the most memory consumption occurs, is essentially unaffected by this algorithm. High Bandwidth Memory (HBM), the product category driving the strongest revenue growth at Micron and its peers, remains essential for training workloads.
There's also the Jevons paradox to consider: by making AI inference cheaper and more memory-efficient, TurboQuant could accelerate the deployment of LLMs into edge devices, smartphones, and IoT applications, all categories that would create entirely new memory demand that doesn't exist today.
SNDK and MU Stock’s Still Boast TailwindsMicron’s earnings last week were quite exceptional. The company delivered February-quarter earnings that beat guidance by 45%, and its May-quarter earnings guidance effectively doubled consensus estimates. Revenue nearly tripled year-over-year, and net income surged almost 10x. MU currently trades at roughly 6x forward earnings, the cheapest forward P/E in the entire S&P 500 after its recent 23% post-earnings slide from record highs.
SanDisk's fundamentals tell a similar story. SNDK reported Q2 fiscal 2026 EPS of $6.20, beating forecasts by nearly 78%, with revenue up 61% year-over-year. Gross margins expanded dramatically to 51.1% from 29.9% in the prior quarter, and management guided Q3 revenue to $4.4–$4.8 billion with gross margins of 65–67%. The company is actively signing long-term supply agreements and projecting 75–100 exabytes of AI-related storage demand by 2027.
While investor focus remains fixated on Alphabet’s research breakthroughs, the more relevant risk to these stocks is not technological obsolescence driven by research, but the inherently cyclical nature of the memory and storage industry itself. Historically, these businesses have been defined by periods of undersupply followed by aggressive capacity expansion, which ultimately leads to pricing pressure and margin compression. In that context, the eventual end of this cycle is far more likely to be driven by supply-demand dynamics normalizing than by any single leap forward in AI capabilities.
In the chart below, we can see that Micron stock has traded down to a clear level of support following the earnings, and Alphabet news driven selloff. For now, it appears to be holding at support. Investors can keep an eye on this level to determine where the next move may be.
Image Source: TradingView
The AI Buildout Shows Few Signs of SlowingAlphabet's TurboQuant is a legitimate technical achievement. It will likely reduce the cost of AI inference over time, and GOOGL stands to benefit directly through lower operating costs across its cloud and search infrastructure. But the leap from "6x compression of the KV cache" to "the AI memory boom is over" may be a narrative stretched too far.
The memory cycle is driven by supply-demand dynamics that operate on multi-year capex timelines, not by individual research papers. Samsung, SK Hynix, and Micron have all constrained supply in recent quarters precisely because the industry learned its lesson from the brutal 2022–2023 downturn. Demand from hyperscale data center buildouts, where Meta alone recently committed $27 billion in a single deal with Nebius, shows no signs of abating.
For investors in Micron and SanDisk, this week's pullback looks more like a gift than a warning. Both stocks are Zacks Rank #1 names with accelerating earnings, strengthening margins, and valuations that have moderated in the last couple of weeks.
2026-03-27 17:451mo ago
2026-03-27 13:411mo ago
Here's Why You Should Add EXC Stock to Your Portfolio Right Now
Key Takeaways EXC has a 6% long-term earnings growth rate and a 9.53% average earnings surprise over four quarters.EXC plans $41.3B in investments from 2026-2029 to boost grid reliability and drive rate-base growth.EXC shares jumped 10.9% in three months, beating industry growth, with a 3.47% dividend yield. Exelon (EXC - Free Report) focuses on consistent investments in infrastructure upgrades to better serve its customers. The company is also steadily expanding its generation assets. Given its strong growth prospects, EXC makes for a solid investment option in the Zacks Utility Electric Power industry.
Let us focus on the reasons that make this Zacks Rank #2 (Buy) stock a strong investment pick at the moment.
EXC’s Growth Outlook & Surprise HistoryThe Zacks Consensus Estimate for 2026 earnings per share (EPS) is pegged at $2.85, which indicates year-over-year growth of 2.9%.
The consensus estimate for 2026 sales is $25.19 billion, which indicates year-over-year growth of 3.9%.
EXC’s long-term (three to five years) earnings growth rate is 6%.
The company delivered an average earnings surprise of 9.53% in the last four quarters.
EXC Stock Dividend YieldEXC distributes dividends to shareholders on a regular basis. The board declared a quarterly dividend of 42 cents per share, which implies an annualized dividend of $1.68. Management continues to target dividend growth consistent with its longer-term earnings and payout framework, subject to board approval. Its current dividend yield is 3.47%, which is better than the industry’s average of 3.08%.
Solvency of EXC StockThe company’s time-to-interest earned ratio at the end of the fourth quarter was 2.55. The ratio, being greater than one, reflects its ability to meet future interest obligations without difficulties.
EXC’s InvestmentsExelon continues to invest heavily in infrastructure while maintaining a strong focus on grid reliability and modernization. The company’s current four-year capital plan outlines an investment of $41.3 billion for the 2026–2029 period. These funds will be allocated across distribution, transmission and gas delivery to better serve customers and strengthen system resilience.
This structured investment approach is expected to drive steady rate-base growth and remains a key factor supporting the company’s long-term adjusted operating earnings growth outlook.
EXC Stock Price PerformanceIn the past three months, EXC shares have risen 10.9% compared with the industry’s growth of 3.5%.
Image Source: Zacks Investment Research
Other Stocks to ConsiderSome other top-ranked stocks from the same industry are NiSource (NI - Free Report) , Duke Energy (DUK - Free Report) and Entergy Corporation (ETR - Free Report) , each carrying a Zacks Rank of 2 at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
NiSource’s long-term earnings growth rate is 6%. The Zacks Consensus Estimate for NI’s 2026 EPS implies an improvement of 7.9% year over year.
The consensus estimate for DUK’s 2026 EPS implies an improvement of 6.3% year over year. The company delivered an average earnings surprise of 4.77% in the last four quarters.
ETR’s long-term earnings growth rate is 11.5%. The Zacks Consensus Estimate for ETR’s 2026 EPS implies an improvement of 12.8% year over year.
2026-03-27 17:451mo ago
2026-03-27 13:411mo ago
Nu Holdings Converts 131M Customers Into Powerful Profit Growth
Key Takeaways NU reached 131M customers in Q4 2025, with Brazil accounting for 62% of the country's adult population.NU posted $4.9B in revenues ( 45% YoY), $2B gross profit, and $895M net income, up 50% year over year.NU stock is down 16% YTD, trades at 14.75 forward P/E vs. the industry's 10.07. Nu Holdings (NU - Free Report) has reached a scale in Latin America that many fintechs can only dream of. In the fourth quarter of 2025, the company counted 131 million customers across its footprint, with Brazil alone accounting for 62% of the adult population using its platform.
Such breadth is translating into powerful financial performance. Quarterly revenues came in at $4.9 billion, rising 45% year over year. At the same time, gross profit surged to $2 billion, up 38% year over year. While many U.S. fintech peers continue to burn cash, Nu Holdings reported $895 million in net income in the fourth quarter, climbing 50% year over year.
The interplay is clear: rapid customer adoption feeds top-line growth, credit drives gross profit, and disciplined execution ensures bottom-line strength. Brazil is the anchor, but Mexico and Colombia are adding meaningful momentum. Nu Holdings isn’t merely scaling; it’s scaling profitably and at a pace that places it well ahead of many fintech rivals.
By demonstrating that growth and profitability don’t have to be mutually exclusive, NU is carving out a rare position in digital banking: a fintech giant that’s already highly profitable, yet still in the middle of a steep growth curve.
Peer Pressure?While Nu Holdings continues to surge ahead in Latin America, U.S.-based peers like SoFi Technologies (SOFI - Free Report) and Block (XYZ - Free Report) are taking different routes to growth. SoFi is focusing on deepening customer relationships through bundled financial services like lending, investing and banking. Its strategy seems to emphasize lifetime value over rapid user expansion. Meanwhile, Block is sharpening its dual ecosystem approach, serving both individual users through Cash App and small businesses via Square.
While both SoFi and Block are evolving steadily, NU’s pace and scale of customer acquisition in emerging markets underscore a distinct momentum that sets it apart in the global fintech landscape.
NU’s Price Performance, Valuation, EstimatesThe stock has declined 16% year to date compared to the industry’s 4% decline.
Image Source: Zacks Investment Research
From a valuation standpoint, NU trades at a forward price-to-earnings ratio of 14.75, which is well above the industry’s 10.07. It carries a Value Score of C.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for NU’s 2026 earnings has been on the rise over the past 30 days.
NU stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
2026-03-27 17:451mo ago
2026-03-27 13:411mo ago
Palantir Price Prediction: Where Will The AI Stock Be In 2030?
Tech giant Palantir Technologies (NASDAQ:PLTR | PLTR Price Prediction) is one of the most debated AI stocks in the market. With a current price of $154.78, the stock has delivered a remarkable run but now trades well below its 52-week high of $207.52. Our 24/7 Wall St. Price Target for Palantir is $171.26, representing a 10.65% total return over the next 12 months, with a 90% confidence level.
Metric Value Current Price $154.78 24/7 Wall St. Price Target $171.26 Upside +10.65% 24/7 Wall St. Rating Bullish Confidence Level 90% A Volatile Start to 2026 Palantir has had a turbulent 2026. The stock is down 12.92% year-to-date, pulling back from a year-end 2025 price of $177.75, though shares have recovered up 14.45% from the February low. The one-year picture remains compelling: the stock is up 59.98% over the past 12 months and sits 10% below its 52-week high.
In the fourth-quarter, Palantir posted revenue of $1.41 billion, up 70% year-over-year, beating consensus by 5.74%, with adjusted EPS of $0.25 versus the $0.18 consensus. Full-year 2025 revenue reached $4.475 billion, up 56.18% year-over-year, while free cash flow nearly doubled to $2.27 billion.
Why Bulls See a Path to $200 and Beyond The bull case centers on an AI commercial adoption curve still in early innings. U.S. commercial revenue accelerated from 71% year-over-year growth in Q1 2025 to 137% year-over-year in Q4 2025, reaching $507 million in the quarter. Management’s 2026 guidance calls for U.S. commercial revenue to exceed $3.144 billion, representing at least 115% growth, and net dollar retention of 139% means existing customers are compounding the top line without requiring new acquisition.
Besides the strong financials, the company is firing on all cylinders. It has impressed the market with U.S. commercial revenue growth and is no longer focused solely on government contracts. While it has recently been awarded an FCA contract and its AI will be adopted by Pentagon as a core military system, the company has several commercial contracts for the coming years. It has partnered with Nvidia, Centrus Energy, Rio Tinto, and Polymarket, to name a few.
What Could Go Wrong At a P/E of 255x, Palantir prices in extraordinary execution over many years. Any deceleration in U.S. commercial growth, a federal budget shift away from defense AI, or a broader AI spending pullback could compress the multiple sharply. The bear case shows a path to $137.73 by March 2027, a -11.01% decline from today.
Palantir’s GAAP profitability is real and growing: GAAP net income reached $1.625 billion for full-year 2025, up 251.59% year-over-year. The company carries minimal debt, with total liabilities of just $1.41 billion against $8.9 billion in total assets.
The Bottom Line: Buy With Eyes Open The 24/7 Wall St. Price Target of $171.26 reflects a stock with exceptional fundamentals trading at a valuation that demands perfection. The earnings trajectory, pipeline visibility, and margin expansion make the 90% confidence level defensible despite a beta of 1.74. The FY 2026 revenue guidance of $7.18 to $7.20 billion and the guided Rule of 40 score of 118% are the key metrics to watch. Palantir’s risk-reward at current prices reflects a high-conviction setup for those already following the stock.
The market is bullish on PLTR and has upgraded the price target. UBS and Rosenblatt analyst has a price target of $200 with a buy rating. The upgrade was followed by reports that Palantir is developing software for Golden Dome Missile Shield.
Palantir Price Prediction 2026 to 2030 Year 24/7 Wall St. Price Target 2026 $171.26 2027 $185 2028 $200 2029 $215 2030 $226.11 The 2030 base case of $226.11 reflects a 46.08% total return from current levels, with the bull scenario reaching $294.18 (89.95% return) and the bear scenario at $138.22 (-10.71%). These projections assume continued execution on Palantir’s AI platform strategy and U.S. commercial expansion. Significant upside or downside could result from shifts in federal AI spending policy, international market breakthroughs, or a broader rerating of AI software multiples.
2026-03-27 17:451mo ago
2026-03-27 13:421mo ago
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Driven Brands Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DRVN
New York, New York--(Newsfile Corp. - March 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Driven Brands Holdings Inc. (NASDAQ: DRVN) between May 9, 2023 and February 24, 2026, both dates inclusive (the "Class Period"), of the important May 8, 2026 lead plaintiff deadline.
SO WHAT: If you purchased Driven Brands common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Driven Brands class action, go to https://rosenlegal.com/submit-form/?case_id=18662 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 8, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose Driven Brands' financial condition and the effectiveness of its internal controls over financial reporting through a series of inaccurate financial reports filed with the Securities and Exchange Commission ("SEC") from May 9, 2023, to November 5, 2025. Among many other errors, Driven Brands' balance sheets contained an unreconciled cash balance originating in 2023 which resulted in revenue and cash being overstated in 2023 and 2024, and operating expenses being understated over the same period. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Driven Brands class action, go to https://rosenlegal.com/submit-form/?case_id=18662 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/290238
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Contact Us
2026-03-27 17:451mo ago
2026-03-27 13:421mo ago
Broadcom Stock Price Prediction: Where Will AVGO Be in 3 Years?
Broadcom (NASDAQ:AVGO | AVGO Price Prediction) has been one of the defining semiconductor stories of the AI era. Trading at $322.51, the stock sits 14% below its 52-week high of $412.95 despite a business accelerating in nearly every dimension. Our Price Target for Broadcom is $352.37, implying 9.26% upside over the next 12 months. The 24/7 Wall St. model confidence level is 90%.
Metric Value Current Price $322.51 24/7 Wall St. Price Target $352.37 Upside 9.26% Analyst Consensus Bullish Confidence Level 90% A Rally Built on Real Results Broadcom has climbed 69.63% over the past year, though the stock is down 6.63% year-to-date and off 2.85% over the past month. The pullback comes despite a blowout Q1 FY2026 earnings report.
Revenue came in at $19.31 billion, up 29.47% year-over-year, beating consensus of $19.14 billion. Non-GAAP diluted EPS of $2.05 cleared estimates of $2.02. AI semiconductor revenue hit $8.4 billion, up 106% year-over-year, exceeding the company’s own forecast. Adjusted EBITDA margins held at a record 68%, while free cash flow reached $8.01 billion, up 33.21% year-over-year. Overall, the numbers are impressive.
The Case for $450 and Beyond The bull case centers on AI revenue acceleration that has consistently outrun expectations. CEO Hock Tan has set a public goal of exceeding $100 billion in AI sales by 2027.
With Q2 FY2026 guidance calling for AI semiconductor revenue of $10.7 billion and total revenue of approximately $22 billion, up 47% year-over-year, the trajectory supports that ambition. The company has secured five XPU customers including Google, Anthropic, and Apple, and carries a $73 billion AI backlog expected to be delivered over the next 18 months, with management noting the backlog is expected to grow.
Tan stated, “We have never seen bookings of the nature that what we have seen over the past three months.” The bull case 1-year price target reaches $450.17, and the consensus analyst target stands at $472.01 with 48 buy ratings and zero sell ratings.
What Could Go Wrong The primary risk is customer concentration. A significant portion of AI revenue flows from a small number of hyperscale cloud customers. Any slowdown in their capex cycles or a shift toward GPU-based infrastructure could pressure results. Broadcom also carries meaningful debt, and the trailing P/E of 63x leaves little room for execution missteps.
Non-AI semiconductor revenue remains subdued, with management guiding for stability rather than recovery in enterprise markets. The company depends heavily on TSMC for 2nm and 3nm wafer capacity, introducing geopolitical risk. The bear case from our model points to $283.65 over 12 months.
Tan addressed margin concerns directly: “The AI revenue has a lower gross margin than our obviously, the rest of the business, including software, of course. But we expect the rate of growth to offer as we do more and more AI revenue to be so so much that we get the operating leverage on our operating spending that operating margin won’t deliver dollars that are still a high level of growth.”
Broadcom is also building an advanced packaging facility in Singapore to reduce supply chain exposure.
The AI Payoff and the Valuation Math The 24/7 Wall St. Price Target reflects a business firing on all cylinders but priced for near-perfection. Our model carries 90% confidence in this range, supported by AI revenue acceleration, a $73 billion backlog, and a nearly unanimous analyst community.
The key variable is the Q2 FY2026 AI revenue print. If Broadcom delivers on its $10.7 billion AI semiconductor guidance or exceeds it, the stock has a clear path toward the analyst consensus target of $472. If a hyperscale customer reduces orders or the backlog shows cancellations, the forward multiple compresses quickly at this valuation.
Wall Street is bullish on the stock with over half a dozen analysts raising the price target after the blow-out results.
Broadcom Price Prediction 2026-2030 Year 24/7 Wall St. Price Target 2026 $341.21 2027 $367.08 2028 $403.15 2029 $429.22 2030 $438.55 These projections assume Broadcom continues converting its AI backlog into revenue while sustaining EBITDA margins near 68%. The 5-year bull case reaches $707.33, contingent on the $100 billion AI revenue target materializing and new customer wins. The 5-year bear case settles at $293.61 if AI capex cycles moderate and multiples compress toward sector averages.
Syn Prop & Tech S.A. (SYYNY) Q4 2025 Earnings Call March 27, 2026 10:00 AM EDT
Company Participants
Thiago Muramatsu - CEO & Member of Board of Executive Officers
Hector Bruno de Carvalho Leitao - Chief Financial & IR Officer, Financial Superintendent & Member of Board of Executive Officer
Conference Call Participants
Gustavo Fabris - Banco BTG Pactual S.A., Research Division
Presentation
Operator
Good morning, ladies and gentlemen. Welcome to the Syn video conference to discuss the results for the fourth quarter of 2025.
This conference is being recorded, and the replay can be accessed on the company's website, ri.syn.com.br. The presentation will be also available for download. Please be advised that all the attendees will only be watching the video conference during the presentation, and then we will start the Q&A session when further instructions will be provided.
For those who are watching the video conference in English, we advise that downloads and these are regarding future events, may differ substantially from the results. Investors, analysts should consider that the events different from the ones expressed in the declaration.
Here present in this video conference. Mr. Thiago Muramatsu and Mr. Hector Leitao, Financial Director of financial investors with the company. I'd like to pass the floor to Mr. Muramatsu to start this presentation. Please, Thiago, the floor is yours.
Thiago Muramatsu
CEO & Member of Board of Executive Officers
Good morning, everybody. Thank you so much for being here. Starting this call, I'd like to validate the fourth quarter 2025. And then we start with the dividends paid BRL 64 million in December. And just to remind you, BRL 64 million additional to the other BRL 400 million that we had in dividends in 2025.
Considering the period since the beginning of transaction of the shopping malls to
2026-03-27 16:451mo ago
2026-03-27 12:361mo ago
Can UnitedHealth's Avery Redefine Healthcare Navigation at Scale?
Key Takeaways UnitedHealth launches Avery, a 24/7 AI assistant integrating claims, coverage and scheduling.UNH says nearly 90% of interactions need no human help, boosting efficiency and support.Avery will expand to 20.5M members, backed by a $1.6B AI investment pipeline. UnitedHealth Group Incorporated (UNH - Free Report) is accelerating its AI investment strategy through UnitedHealthcare with the launch of Avery, a generative AI companion designed to simplify how members interact with the healthcare system. Positioned as a 24/7 digital assistant, Avery integrates coverage details, claims tracking, cost estimates and appointment scheduling into a single conversational interface. It aims to reduce friction in a system often criticized for complexity while improving member engagement and satisfaction.
On the front end, it enables self-service, with nearly 90% of interactions reportedly not requiring human intervention. On the back end, it enhances productivity for customer advocates by providing real-time insights, case histories and seamless handoffs. This combination of automation and human support highlights a larger trend in the industry: AI isn’t here to take over but to enhance and amplify our service capabilities.
Avery aligns with UnitedHealth’s integrated model, where insurance, care delivery and data analytics converge. By steering users toward cost-effective, in-network providers and providing clear upfront pricing, this tool could play a significant role in tackling medical-cost inflation — one of the ongoing challenges the company faces. With plans to expand Avery’s reach to around 20.5 million members and a $1.6 billion AI investment pipeline, scale is clearly a priority.
Execution will be crucial. In the healthcare world, where every detail matters, accuracy, privacy and trust are non-negotiable. While governance frameworks are in place, the real test lies in consistent real-world performance. If Avery executes effectively, it could become a meaningful step toward a more intuitive, consumer-centric healthcare experience — while quietly strengthening UNH’s competitive moat.
How Are Competitors Faring?Some of UNH’s major competitors in the healthcare service provider space are Elevance Health, Inc. (ELV - Free Report) and Humana Inc. (HUM - Free Report) .
Elevance Health is building its AI capabilities around a Virtual Assistant integrated within its digital ecosystem. Focused on member navigation, ELV’s tool enables conversational support for benefits, costs and provider search, reflecting a broader push toward simplifying healthcare access through intelligent automation.
Humana has been steadily embedding AI across member engagement and care management, with a strong tilt toward improving customer interactions and care coordination. HUM’s tools focus on real-time insights, predictive analytics and contextual personalization, helping agents identify friction points early and guide members through complex care journeys more efficiently.
UnitedHealth’s Price Performance, Valuation & EstimatesShares of UNH have declined 48% in the past year compared with the industry’s fall of 42.5%.
Image Source: Zacks Investment Research
From a valuation standpoint, UnitedHealth trades at a forward price-to-earnings ratio of 14.73, above the industry average of 12.97. UNH carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for UnitedHealth’s 2026 earnings is pegged at $17.70 per share, implying 8.3% growth from the year-ago period.
Image Source: Zacks Investment Research
UNH stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
2026-03-27 16:451mo ago
2026-03-27 12:361mo ago
Oil Services ETF (OIH) Hits 52-Week High: More Strength Ahead?
Energy stocks are thriving while the broader market remains under pressure.
In early 2026, with many investors adopting a cautious, bearish stance amid geopolitical tensions, moderating economic growth, and lingering concerns over inflation and interest rates, the VanEck Oil Services ETF has stood out as a notable exception.
The ETF itself has recently touched fresh 52-week highs, and several of its top holdings have also been reaching new heights. This strength is occurring against a backdrop of higher oil prices, driven by supply risks and geopolitical developments, even as the general market has shown signs of fatigue.
Oil Services Gush Higher
Higher oil prices act as a direct tailwind for the services companies that help produce and maintain that oil. When crude stays elevated, operators increase drilling and completion activity, boosting demand for everything from pressure pumping and drilling rigs to subsea equipment and well services.
This dynamic often creates a defensive quality within the energy complex: oil services can deliver growth and margin expansion even when general equity sentiment is subdued.
The OIH ETF (OIH - Free Report) provides a concentrated, liquid way to gain exposure to this theme. It tracks the 25 largest U.S.-listed oil services companies, with heavy weighting toward the largest and most liquid names.
The top 10 holdings in the ETF together make up more than 70% of the fund. This concentration means that when the largest players perform well, the ETF itself moves decisively higher, as we’ve seen with its recent push to new highs.
Let’s examine two of the leading names that have been driving this performance and why they remain appealing even in a cautious market environment.
Weatherford, TechnipFMC Garner Leading Zacks Rank
Weatherford (WFRD - Free Report) has been a notable bright spot, with shares widely outperforming this year. The company’s focus on well construction, completion, and production optimization has resonated in both international and North American markets.
Image Source: StockCharts
Analysts see 2026 revenue in the $4.6–$5.0 billion range with continued margin expansion. WFRD stock carries a Zacks Rank #1 (Strong Buy), reflecting positive revisions and strong cash flow generation. Weatherford’s transformation under new management has delivered consistent outperformance, making it one of the more dynamic names within the OIH basket.
Another leading stock in the current market environment, TechnipFMC (FTI - Free Report) has been one of the more impressive performers within the ETF, recently hitting 52-week highs. The company’s strength in subsea and offshore projects has benefited from a global resurgence in offshore spending.
Image Source: StockCharts
Analysts project 2026 earnings growth of approximately 18%, with revenue gains driven by backlog conversion. FTI also carries a Zacks Rank #1 (Strong Buy) in recent coverage, supported by upward revisions and strong project execution. Its integrated model — combining engineering, procurement, construction, and services — gives it a competitive edge in large-scale offshore developments.
These companies share a common thread: they are beneficiaries of structurally higher oil prices and increased global drilling and completion activity, even as the broader equity market adopts a more cautious tone.
In a bearish or risk-off market environment, oil services can act as a relative safe haven within the energy complex because their revenues are more closely tied to commodity prices than to overall economic growth.
Bottom LineFor investors, the OIH ETF itself offers a convenient, liquid way to gain broad exposure, while the individual names highlighted above provide opportunities for more targeted allocation.
Their ability to hit 52-week highs amid broader caution speaks to the resilience of the underlying fundamentals and the potential for continued outperformance as the year progresses.
The recent strength in the OIH ETF and its top constituents offers a sincere reminder that not all parts of the market move in lockstep. Even in a bearish or uncertain macro backdrop, higher oil prices can create meaningful opportunities in the oil services space.
2026-03-27 16:451mo ago
2026-03-27 12:361mo ago
Why Is Cactus (WHD) Down 5.3% Since Last Earnings Report?
It has been about a month since the last earnings report for Cactus, Inc. (WHD - Free Report) . Shares have lost about 5.3% in that time frame, outperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Cactus due for a breakout? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent drivers for Cactus, Inc. before we dive into how investors and analysts have reacted as of late.
Cactus Q4 Earnings Beat Estimates on Higher Pressure Control RevenuesCactus, Inc. reported fourth-quarter 2025 adjusted earnings of 65 cents per share, which beat the Zacks Consensus Estimate of 58 cents. The bottom line declined from the year-ago quarter’s figure of 71 cents.
Total quarterly revenues of $261 million topped the Zacks Consensus Estimate of $251 million. The top line declined from the year-ago figure of $272 million.
The better-than-expected quarterly results were primarily aided by higher sales of drilling equipment and higher rental income in the Pressure Control segment. Lower customer activity levels affected the Spoolable Technologies segment, partially offsetting the positives.
Business SegmentsFollowing the closure of the FlexSteel acquisition, Cactus started reporting under two business segments — Pressure Control and Spoolable Technologies.
The Pressure Control segment generated revenues of $178.4 million, up from $176.7 million reported in the year-ago quarter. The segment was aided by an increase in the product sold per rig, resulting in higher product revenues. The segment benefited from higher rental income driven by increased customer activity. The figure surpassed our estimate of $169 million.
Adjusted Segment EBITDA for Pressure Control totaled $59.2 million, down from $61.5 million in the prior-year quarter. The reported figure was higher than our estimate of $52.3 million.
Revenues from the Spoolable Technologies segment totaled $84.2 million, down from $96.1 million in the prior-year quarter. The figure beat our estimate of $82.2 million. The segment was affected by lower customer activity levels in the quarter.
Adjusted Segment EBITDA for the Spoolable Technologies totaled $31 million, down from $35 million a year ago. The figure beat our estimate of $28 million.
Capex and Cash FlowCactus’ net capital expenditures for the quarter totaled $4.3 million. Operating cash flow was $72.3 million for the fourth quarter.
Balance SheetCactus had cash and cash equivalents of $123.6 million at the end of the fourth quarter of 2025. The company had no bank debt outstanding as of Dec. 31, 2025.
OutlookWHD expects the U.S. land rig count for the first quarter of 2026 to be relatively flat compared to the fourth quarter of 2025. For full-year 2026, WHD still anticipates net capital expenditures to be in the range of $40-$50 million.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in fresh estimates.
The consensus estimate has shifted -5.69% due to these changes.
VGM ScoresCurrently, Cactus has a subpar Growth Score of D, however its Momentum Score is doing a lot better with a B. Charting a somewhat similar path, the stock has a score of C on the value side, putting it in the middle 20% for value investors.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise Cactus has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.
Performance of an Industry PlayerCactus is part of the Zacks Oil and Gas - Integrated - United States industry. Over the past month, Occidental Petroleum (OXY - Free Report) , a stock from the same industry, has gained 25.1%. The company reported its results for the quarter ended December 2025 more than a month ago.
Occidental reported revenues of $5.42 billion in the last reported quarter, representing a year-over-year change of -20.7%. EPS of $0.31 for the same period compares with $0.80 a year ago.
Occidental is expected to post earnings of $0.44 per share for the current quarter, representing a year-over-year change of -49.4%. Over the last 30 days, the Zacks Consensus Estimate has changed +91.3%.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Occidental. Also, the stock has a VGM Score of B.
2026-03-27 16:451mo ago
2026-03-27 12:361mo ago
Why Is Zoom (ZM) Up 5% Since Last Earnings Report?
It has been about a month since the last earnings report for Zoom Communications (ZM - Free Report) . Shares have added about 5% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Zoom due for a pullback? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent catalysts for Zoom Communications, Inc. before we dive into how investors and analysts have reacted as of late.
Zoom Q4 Earnings Miss Estimates, Revenues Increase Y/YZoom Communications reported fourth-quarter fiscal 2026 adjusted earnings of $1.44 per share, which missed the Zacks Consensus Estimate by 2.7% and increased 2.1% year over year.
Revenues of $1.25 billion beat the consensus mark by 1.18% and increased 5.3% year over year. Adjusting for foreign currency impact, revenues in constant currency were $1.24 billion, up 4.8% year over year.
ZM’s Q4 DetailsEnterprise revenues, which account for 60.7% of total revenues, increased 7.1% year over year to $757.3 million. Online revenues, which represent 39.3% of total revenues, increased 2.6% year over year to $489.7 million.
Customers contributing more than $100,000 in revenues in the trailing 12 months grew 9.3% to 4,468. These customers accounted for 33% of revenues.
The number of enterprise customers at the end of the fiscal fourth quarter was 186,400. In the fourth quarter, 74.9% of total Online MRR came from Online customers with a continued term of service of at least 16 months, down 20 basis points year over year.
The company reported a trailing 12-month net dollar expansion rate for Enterprise customers of 98% and an Online average monthly churn of 2.9%, flat year over year.
ZM’s Non-GAAP Operating DetailsNon-GAAP gross margin in the fiscal fourth quarter was 79.8% compared with 78.8% in the year-ago period, expanding 100 bps.
On a year-over-year basis, Research and development expenses increased 10.8% to $147.4 million. Sales and marketing expenses rose 5.5% to $291.9 million, and general and administrative expenses increased 18.9% to $66.2 million.
Non-GAAP operating income rose 4.6% to $489.7 million year over year. The operating margin was 39.3% compared with 39.5% in the year-ago quarter.
ZM’s Balance Sheet & Cash FlowTotal cash, cash equivalents and marketable securities as of Jan. 31, 2025, were $7.8 billion compared with $7.9 billion as of Oct. 31, 2025.
Net cash provided by operating activities was $354.5 million for the fiscal fourth quarter compared with $629.3 million in the previous quarter.
Free cash flow was $338.4 million compared with $614.3 million in the prior quarter.
ZM’s Q1 & FY27 GuidanceZoom expects its first-quarter fiscal 2027 revenues to be between $1.22 billion and $1.225 billion. Revenues on a constant currency basis are expected to be between $1.212 billion and $1.217 billion.
Non-GAAP income from operations is expected to be between $487 million and $492 million.
Non-GAAP earnings per share (EPS) are expected to be in the range of $1.4-$1.42.
For fiscal 2027, Zoom expects revenues in the range of $5.065-$5.075 billion. Revenues on a constant currency basis are expected to be between $5.054 billion and $5.064 billion.
Non-GAAP income from operations is expected to be between $2.05 billion and $2.06 billion.
Non-GAAP EPS are expected to be in the band of $5.77-$5.81.
The company expects free cash flow between $1.7 billion and $1.74 billion.
How Have Estimates Been Moving Since Then?It turns out, fresh estimates flatlined during the past month.
VGM ScoresAt this time, Zoom has a subpar Growth Score of D, a score with the same score on the momentum front. Charting a somewhat similar path, the stock has a score of C on the value side, putting it in the middle 20% for value investors.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook Zoom has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerZoom is part of the Zacks Internet - Software industry. Over the past month, Pinterest (PINS - Free Report) , a stock from the same industry, has gained 0.8%. The company reported its results for the quarter ended December 2025 more than a month ago.
Pinterest reported revenues of $1.32 billion in the last reported quarter, representing a year-over-year change of +14.3%. EPS of $0.67 for the same period compares with $0.56 a year ago.
Pinterest is expected to post earnings of $0.22 per share for the current quarter, representing a year-over-year change of -4.4%. Over the last 30 days, the Zacks Consensus Estimate has changed -33.2%.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #4 (Sell) for Pinterest. Also, the stock has a VGM Score of B.
2026-03-27 16:451mo ago
2026-03-27 12:361mo ago
Essential Utilities (WTRG) Up 2.5% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for Essential Utilities (WTRG - Free Report) . Shares have added about 2.5% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Essential Utilities due for a pullback? Well, first let's take a quick look at the most recent earnings report in order to get a better handle on the recent drivers for Essential Utilities Inc. before we dive into how investors and analysts have reacted as of late.
Essential Utilities Inc. reported fourth-quarter 2025 operating earnings per share (EPS) of 47 cents, which beat the Zacks Consensus Estimate of 36 cents by 30.56%. The bottom line decreased 29.85% from 67 cents in the year-ago quarter.
WTRG’s fourth-quarter earnings are positively impacted by the increase in rate and natural gas volume, reflecting stronger customer demand. These benefits are more than offset by growth in taxes, along with increased operations and maintenance expenses.
Revenues of WTRGOperating revenues of $699.1 million surpassed the Zacks Consensus Estimate of $589 million by 18.69%. The top line rose 15.67% from the prior-year quarter’s $604.4 million.
WTRG reported total revenues of $2.47 billion in 2025, marking an 18.62% rise from $2.09 billion in 2024.
WTRG’s Segment DetailsEssential Utilities’ regulated water segment generated $329.4 million in revenues, up 8% from $305 million in the fourth-quarter of 2024. The primary drivers of this growth were higher water and wastewater rates.
WTRG’s regulated natural gas segment reported quarterly revenues of $361.3 million, marking a 23% increase from $293.7 million in the fourth quarter of 2024.
Highlights of WTRG’s Q4 ReleaseOperation and maintenance expenses amounted to $200.2 million, up 22.45% from the year-ago figure of $163.5 million due to increases in purchased gas costs, rates across both the water and gas businesses, and gas volume.
Operating income totaled $227 million, up 0.17% year over year.
Interest expenses increased 7.11% to $84.9 million from $79.3 million in the prior-year quarter.
The company continues to expand its operations through acquisitions and organic initiatives. During 2025, the company added 12,700 customers through organic growth, and three acquisitions of water and wastewater systems that were completed in the same period. Since 2015, through closed acquisition, the company added nearly 135,000 wastewater customers.
The new water and natural gas rates approval received by the company in 2025 increased annual revenues by $92.6 million and $8.9 million, respectively.
The new water and gas rate approvals received by the company in the first two months of 2026 are expected to increase annual revenues by $4.6 million and $7.6 million, respectively.
WTRG’s Financial HighlightsCurrent assets amounted to $610.4 million as of Dec. 31, 2025, compared with $485.9 million as of Dec. 31, 2024.
Long-term debt was $8.11 billion as of Dec. 31, 2025, up from $7.37 billion as of Dec. 31, 2024.
The company invested $1.4 billion in 2025 to improve its regulated water and natural gas infrastructure systems and enhance operations and customer service.
Latest Update on the Merger With American Water WorksEssential Utilities is moving forward with its previously announced merger deal with American Water Works by securing the necessary regulatory consents and approvals. During 2025, the company submitted applications for regulatory clearance in the applicable states.
On Feb. 10, 2026, shareholders of both companies voted in favor of the proposed merger. The merger is expected to close by the end of the first quarter of 2027.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in estimates review.
VGM ScoresCurrently, Essential Utilities has a poor Growth Score of F, a score with the same score on the momentum front. Charting a somewhat similar path, the stock has a score of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of this revision indicates a downward shift. Notably, Essential Utilities has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
Performance of an Industry PlayerEssential Utilities is part of the Zacks Utility - Water Supply industry. Over the past month, American States Water (AWR - Free Report) , a stock from the same industry, has gained 1.6%. The company reported its results for the quarter ended December 2025 more than a month ago.
American States Water reported revenues of $164.28 million in the last reported quarter, representing a year-over-year change of +14.8%. EPS of $0.74 for the same period compares with $0.69 a year ago.
For the current quarter, American States Water is expected to post break-even earnings per share, indicating a change of 0% from the year-ago quarter. The Zacks Consensus Estimate has changed 0% over the last 30 days.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #2 (Buy) for American States Water. Also, the stock has a VGM Score of C.
2026-03-27 16:451mo ago
2026-03-27 12:361mo ago
Why Is Urban Outfitters (URBN) Down 9.9% Since Last Earnings Report?
It has been about a month since the last earnings report for Urban Outfitters (URBN - Free Report) . Shares have lost about 9.9% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Urban Outfitters due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the latest earnings report in order to get a better handle on the important drivers.
URBN Q4 Earnings & Sales Beat Estimates on Strong Brand MomentumUrban Outfitters reported impressive results in fourth-quarter fiscal 2026, wherein the top and bottom lines beat the Zacks Consensus Estimate. Also, both metrics improved from the prior-year quarter’s reported figure.
URBN’s Quarterly Performance: Key Metrics & InsightsThis lifestyle specialty retailer delivered earnings per share of $1.43, surpassing the Zacks Consensus Estimate of $1.24. Also, the bottom line increased 37.5% from the prior-year quarter.
Total net sales increased 10.1% year over year to $1,801.8 million, surpassing the consensus estimate of $1,787 million.
Total net sales in the Retail segment rose 7.7% year over year, with comparable net sales in this segment increasing 5.5%. The rise in comparable Retail sales was driven by mid-single-digit increases across both digital channel and brick-and-mortar store sales. Within the segment, comparable Retail segment net sales grew 9.6% at Urban Outfitters, 3.7% at Anthropologie and 5.2% at Free People.
In the Wholesale segment, net sales rose 9.1%, driven by a 10.2% increase in Free People Wholesale revenues, largely attributable to higher sales to specialty customers.
Nuuly, a women’s apparel subscription rental service, saw a significant 42.6% increase in net sales, primarily reflecting a 40.3% rally in average active subscribers compared with the same quarter last year.
Margin & Cost Insights of Urban OutfittersGross profit rose 13.6% from the prior-year quarter to $599.2 million. Also, the gross margin expanded 101 basis points (bps) to 33.3%. The gross margin improvement was driven by improved Retail segment markdowns, reflecting reduced markdown activity at Urban Outfitters and Free People. The improvement also benefited from leverage in store occupancy costs resulting from higher comparable Retail segment net sales, as well as leverage in delivery expenses due to fewer packages shipped per order. These gains were partially offset by deleverage in initial merchandise costs.
The rise in gross profit was driven by increased net sales and margin expansion. During the year, the company recorded $2 million in store impairment charges.
The Retail segment’s gross profit rose 12% year over year to $540.3 million, with the segmental gross margin expanding 136 basis points to 34.5%. Wholesale segment gross profit increased 6% to $20.4 million, though its gross margin contracted 75 basis points to 27.3%. Subscription segment gross profit grew 46% to $38.5 million, with the gross margin improving 51 basis points to 24%.
Selling, general and administrative (SG&A) expenses rose 9.5% year over year to $440.5 million. This increase was mainly due to higher marketing investments to support customer growth, and increased sales in the Retail and Subscription segments, along with higher store payroll expenses to support net sales growth in the Retail segment stores.
As a percentage of net sales, SG&A leveraged 14 bps to 24.5% in the quarter under review. This increase was primarily driven by leverage in store payroll costs resulting from net sales growth at Retail segment stores.
URBN recorded an operating income of $158.7 million, up 26.6% from $125.3 million in the prior-year quarter. As a rate of sales, the operating margin increased 115 basis points year over year at 8.8%, primarily driven by gross margin improvement.
URBN’s Store UpdateIn the fiscal fourth quarter, this company opened 42 retail locations, which included five Urban Outfitters stores, nine Anthropologie stores and 28 Free People stores (including 17 FP Movement stores). Also, it closed one Anthropologie store, three Free People stores and 8 Urban Outfitters stores.
In fiscal 2027, the company plans to open 57 stores and close 14 stores. Net new store growth is primarily driven by the expansion in FP Movement, Free People and Anthropologie locations. Specifically, the company expects to open 21 FP Movement stores, 13 Free People stores, 14 Anthropologie stores and 8 Urban Outfitters stores during fiscal 2027.
Urban Outfitters’ Financial Health SnapshotAs of Jan. 31, 2026, URBN had cash and cash equivalents of $369.2 million, and total shareholders’ equity of $2.82 billion. Including marketable securities, total liquidity exceeded $1.1 billion, with no borrowings under its $350 million asset-backed credit facility.
Total inventory increased 12.8% year over year to $700.9 million. Retail segment inventory increased 13.4%, while comparable Retail segment inventory rose 5.3%. Wholesale segment inventory increased 8.5%. Inventory growth was primarily aligned with higher sales and the timing of receipts.
For fiscal 2026, the company generated $575.2 million in cash from operating activities, and capital expenditure totaled $260.2 million. The company repurchased and retired 3.3 million shares for approximately $154 million in fiscal 2026. As of Jan. 31, 2026, 14.6 million common shares remained authorized for repurchase under the program.
URBN’s Q1 OutlookFor the first quarter of fiscal 2027, Urban Outfitters expects to deliver positive high-single-digit total company sales growth. This outlook is supported by anticipated mid-single-digit comparable sales growth in the Retail segment.
Brand-wise, within Retail, comparable sales are projected to rise in the high-single digit at Urban Outfitters, mid-single digit at Free People and low-single digit at Anthropologie. The Subscription segment, led by Nuuly, is expected to deliver mid-double-digit revenue growth in the quarter. The Wholesale segment is projected to post mid-teen revenue growth in the fiscal first quarter.
On the margin front, fiscal first-quarter gross profit margin is expected to decline 25-50 basis points year over year. This outlook excludes a non-recurring gain recorded in the first quarter of fiscal 2026, which positively impacted last year’s gross margin by approximately $5 million, or 36 basis points. The anticipated year-over-year decline is primarily due to lower IMU, driven by higher tariff costs.
Selling, general and administrative expenses are expected to grow several percentage points faster than sales in the fiscal first quarter. The increase is primarily related to the timing of marketing investments at Nuuly and Anthropologie, along with increased technology investments. Management noted that the gap between SG&A growth and sales growth will likely be more pronounced in the first half of the year compared with the second half.
Urban Outfitters’ FY27 GuidanceFor fiscal 2027, Urban Outfitters expects high-single-digit total company sales growth. This outlook is driven by projected mid-single-digit comparable sales growth in the Retail segment, mid-double-digit revenue growth in the Subscription segment and mid-single-digit revenue growth in the Wholesale segment.
The gross margin for fiscal 2027 is expected to expand 25 basis points from the prior year, with the second half reflecting a benefit to IMU. This outlook reflects the tariffs in place prior to the Supreme Court ruling overturning the IEEPA tariffs this past Friday.
SG&A expenses are expected to grow faster than sales for the full year. The increase in SG&A dollars is primarily related to strategic technology investments to support Nuuly’s continued expansion and to accelerate the internal product lifecycle through the implementation of Agentic AI tools. These investments are expected to drive long-term benefits, including improved speed to market, enhanced decision-making closer to customer demand, higher sales and lower markdowns.
Inventory is expected to increase at the same rate as sales or slower in fiscal 2027. Capital expenditure for fiscal 2027 is planned at $385 million. Approximately 40% of spending will be allocated toward retail store expansion and support, 40% toward logistics investments to expand capacity and automation in both the Subscription and Retail segments, and the remaining 20% will be spent on technology investments and home office expansion.
How Have Estimates Been Moving Since Then?It turns out, estimates revision have trended downward during the past month.
The consensus estimate has shifted -9.88% due to these changes.
VGM ScoresAt this time, Urban Outfitters has a strong Growth Score of A, though it is lagging a bit on the Momentum Score front with a B. Charting a somewhat similar path, the stock was allocated a score of A on the value side, putting it in the top 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Urban Outfitters has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
2026-03-27 16:451mo ago
2026-03-27 12:361mo ago
Veracyte (VCYT) Down 15.4% Since Last Earnings Report: Can It Rebound?
It has been about a month since the last earnings report for Veracyte (VCYT - Free Report) . Shares have lost about 15.4% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Veracyte due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the latest earnings report in order to get a better handle on the important drivers.
Veracyte Q4 Earnings Beat Estimates, Revenues Up Y/YVeracyte, Inc. (VCYT - Free Report) delivered fourth-quarter 2025 adjusted earnings of 53 cents per share, up 47.2% from the year-ago period. The bottom line beat the Zacks Consensus Estimate by 30.06%.
The company’s GAAP earnings per share were 52 cents compared with the year-ago period’s 7 cents per share.
Full-year 2025 EPS grew 49.6% year over year to $1.78. The figure surpassed the Zacks Consensus Estimate by 6.2%.
VCYT’s RevenuesRevenues increased 18.5% year over year to $140.6 million, which outpaced the Zacks Consensus Estimate by 1.4%.
The company reported 2025 revenues of $517.1 million, which increased 16% from the prior-year level. The figure surpassed the Zacks Consensus Estimate by 0.4%.
VCYT’s Q4 Segmental DetailsTesting revenues totaled $135.8 million, up 21.1% year over year, driven by Decipher and Afirma revenue growth of 27% and 16%, respectively. Total testing volume was roughly 45,500, reflecting an increase of 16% year over year.
Product revenues increased 27% year over year to $3 million in the fourth quarter.
Biopharmaceutical and other revenues of $962 million reflected a 72.2% decrease from the prior-year quarter’s level, given the restructuring and liquidation proceedings of Veracyte SAS.
VCYT’s Q4 MarginsThe total cost of revenues (product, testing, biopharmaceutical and other) was $36 million, down 3% year over year.
The gross profit rose 28.3% to $104.7 million. The gross margin expanded 568 basis points (bps) to 74.4%.
Selling and marketing expenses rose 4.5% to $25.9 million, while general and administrative expenses fell 35.5% to $17 million. R&D expenses totaled $20.8 million, up 8.1% year over year. The adjusted operating margin was 28.8% compared with 8.9% in the prior-year quarter.
VCYT’s Cash, Capital Structure & SolvencyVeracyte exited fourth-quarter 2025 with cash and cash equivalents of $362.6 million compared with $239.1 million at the end of 2024.
The cumulative net cash provided from operating activities at the end of the reported quarter was $136.3 million compared with $75.1 million a year ago.
VCYT’s 2026 GuidanceVeracyte reiterated its 2026 guidance, originally issued with its preliminary fourth-quarter financial report in January. The company expects revenues in the range of $570 million to $582 million, implying growth of 10-13%, with testing revenues projected to increase 14-16%. The Zacks Consensus Estimate for revenues is currently pegged at $577.3 million.
The adjusted EBITDA margin is expected to be 25% for 2026.
How Have Estimates Been Moving Since Then?It turns out, estimates revision flatlined during the past month.
The consensus estimate has shifted -5.21% due to these changes.
VGM ScoresAt this time, Veracyte has a strong Growth Score of A, though it is lagging a lot on the Momentum Score front with a C. Following the exact same course, the stock has a score of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook Veracyte has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerVeracyte is part of the Zacks Medical - Instruments industry. Over the past month, Inogen (INGN - Free Report) , a stock from the same industry, has gained 0.9%. The company reported its results for the quarter ended December 2025 more than a month ago.
Inogen reported revenues of $81.72 million in the last reported quarter, representing a year-over-year change of +2%. EPS of -$0.26 for the same period compares with -$0.41 a year ago.
Inogen is expected to post a loss of $0.24 per share for the current quarter, representing a year-over-year change of +4%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.
Inogen has a Zacks Rank #4 (Sell) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of B.
2026-03-27 16:451mo ago
2026-03-27 12:361mo ago
Marriott Vacations Worldwide (VAC) Up 3.8% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for Marriott Vacations Worldwide (VAC - Free Report) . Shares have added about 3.8% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Marriott Vacations Worldwide due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.
Marriott Vacations Q4 Earnings Top Estimates, Revenues MissMarriott Vacations reported mixed results for its fourth quarter of 2025, with adjusted earnings beating the Zacks Consensus Estimate, while revenues missed the same. Meanwhile, both metrics declined year over year.
In the fourth quarter, results at Marriott Vacations were supported by the strength of the company’s brands, high-quality resort portfolio and resilient recurring revenue base. Management noted that Adjusted EBITDA came in toward the high end of guidance, reflecting disciplined execution despite a challenging operating environment. Entering 2026, management is prioritizing profitability, cost discipline, capital allocation, inventory reduction and stronger cash flow generation while taking decisive actions to enhance long-term performance.
However, consolidated contract sales declined due to lower tour flow and a modest reduction in volume per guest, resulting in softer development profit and some margin compression during the quarter.
Q4 Earnings & Revenue PerformanceAdjusted earnings per share of $1.86 surpassed the Zacks Consensus Estimate of $1.72 by 8.1%. In the year-ago quarter, it reported an adjusted EPS of $1.98.
Quarterly revenues of $1.323 billion missed the consensus mark of $1.325 billion by 0.1% and decreased 0.3% on a year-over-year basis.
Segment Highlights of VACVacation Ownership: Revenues (excluding cost reimbursements) declined 3% year over year to $792 million. Consolidated contract sales were $458 million, down 4% year over year, as both tours and VPG declined 3% and 1%, respectively. Segment adjusted EBITDA decreased 1% to $221 million, with margin expanding 70 bps to 27.9%.
Exchange & Third-Party Management: Revenues declined 5% year over year to $47 million, reflecting lower Interval International revenues. Adjusted EBITDA fell 13% to $19 million, with margin contracting 380 bps to 40.6%.
Corporate and Other: Expenses rose $8 million compared to the prior-year quarter.
Q4 Margins & ProfitabilityAdjusted EBITDA fell 3% year over year to $186 million, translating to a 21.7% margin, which remained unchanged year over year.
Adjusted operating income fell to $95 million, marking a 10% decrease.
Balance Sheet & LiquidityThe company ended the fourth quarter with $1.4 billion in liquidity, comprising $406 million of cash and equivalents and $787 million in available credit.
Total inventory stood at $916 million, while debt included $3.5 billion in corporate debt and $2.1 billion in non-recourse securitized debt tied to vacation ownership notes receivable.
During the fourth quarter of 2025, the company completed its second securitization transaction of the year, issuing $470 million in vacation ownership notes. The transaction carried a gross advance rate of 98% and a blended interest rate of 4.62%.
VAC’s 2025 HighlightsRevenues for 2025 came in at $5.03 billion compared with $4.97 billion reported in 2024.
Adjusted EBITDA in 2025 came in at $751 million compared with $736 million reported in 2024.
In 2025, adjusted EPS came in at $7.16 compared with $6.72 reported in the previous year.
2026 Outlook Provided by VACFor 2026, Marriott Vacations expects contract sales to range between $1,745 million and $1,815 million, while adjusted EBITDA is projected to be in the range of $755 million to $780 million.
Adjusted net income is anticipated to come in between $255 million and $285 million, with adjusted diluted earnings per share estimated at $7.05 to $7.80. The company also expects to generate adjusted free cash flow in the range of $375 million to $425 million.
How Have Estimates Been Moving Since Then?It turns out, estimates review flatlined during the past month.
The consensus estimate has shifted 7.27% due to these changes.
VGM ScoresCurrently, Marriott Vacations Worldwide has a subpar Growth Score of D, however its Momentum Score is doing a bit better with a C. Charting a somewhat similar path, the stock has a grade of B on the value side, putting it in the second quintile for value investors.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook Marriott Vacations Worldwide has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerMarriott Vacations Worldwide belongs to the Zacks Leisure and Recreation Services industry. Another stock from the same industry, Expedia (EXPE - Free Report) , has gained 6.8% over the past month. More than a month has passed since the company reported results for the quarter ended December 2025.
Expedia reported revenues of $3.55 billion in the last reported quarter, representing a year-over-year change of +11.4%. EPS of $3.78 for the same period compares with $2.39 a year ago.
Expedia is expected to post earnings of $1.31 per share for the current quarter, representing a year-over-year change of +227.5%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.
Expedia has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of B.
2026-03-27 16:451mo ago
2026-03-27 12:361mo ago
United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for United Therapeutics (UTHR - Free Report) . Shares have added about 5.7% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is United Therapeutics due for a pullback? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent catalysts for United Therapeutics Corporation before we dive into how investors and analysts have reacted as of late.
Q4 Earnings Beat, Sales Miss Estimates
United Therapeutics reported fourth-quarter 2025 EPS of $7.70, which surpassed the Zacks Consensus Estimate of $6.78. Earnings increased 24% year over year, driven by higher product sales.
Revenues in the fourth quarter were $790.2 million. Revenues missed the Zacks Consensus Estimate of $805 million. Revenues rose 7.3% year over year, driven by growth of key products — Tyvaso and Orenitram.
Quarter in Detail
Combined Tyvaso sales were $464.3 million, up 12% year over year. Tyvaso sales missed the Zacks Consensus Estimate of $488 million.
Tyvaso DPI generated revenues of $338.6 million, up 24% year over year, supported by stronger commercialization efforts following changes to Medicare Part D under the Inflation Reduction Act, which boosted patient uptake and volumes.
Revenues from nebulized Tyvaso (treprostinil) were $125.7 million, down 12%, due to lower volumes.
Sales of Orenitram rose 12% year over year to $121.2 million, primarily driven by higher volumes and improved commercialization efforts.
Remodulin (including Remunity Pump) sales declined 5% year over year to $128 million.
Unituxin sales were down 8% year over year to $62.3 million.
Adcirca sales were $7.8 million, up 66% year over year.
Research and development expenses were $139.5 million in the quarter, up 4.3% year over year, reflecting higher clinical development costs and increased share-based compensation.
Selling, general and administrative expenses increased 13.1% to $190.6 million in the quarter, primarily driven by increased consulting expenses and personnel costs tied to headcount expansion.
As of Dec. 31, 2025, United Therapeutics had cash, cash equivalents and investments of $4.6 billion compared with $4.3 billion as of Sept. 30, 2025. It had no debt.
UTHR’s Full-Year 2025 Results
For 2025, United Therapeutics reported total revenues of $3.18 billion, up 11% year over year.
For full-year 2025, the company recorded net earnings of $27.86 per share, higher than the EPS of $24.64 reported in 2024.
2026 Outlook
United Therapeutics expects “double-digit revenue growth” in 2026.
The company also said that it expects to reach $4 billion in annualized revenue run rate in the second half of 2027.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in fresh estimates.
VGM ScoresAt this time, United Therapeutics has a average Growth Score of C, though it is lagging a lot on the Momentum Score front with an F. However, the stock was allocated a score of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of this revision indicates a downward shift. Interestingly, United Therapeutics has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerUnited Therapeutics is part of the Zacks Medical - Drugs industry. Over the past month, Madrigal (MDGL - Free Report) , a stock from the same industry, has gained 16.4%. The company reported its results for the quarter ended December 2025 more than a month ago.
Madrigal reported revenues of $321.08 million in the last reported quarter, representing a year-over-year change of +210.8%. EPS of -$2.57 for the same period compares with -$2.71 a year ago.
Madrigal is expected to post a loss of $3.62 per share for the current quarter, representing a year-over-year change of -9%. Over the last 30 days, the Zacks Consensus Estimate has changed -52.8%.
Madrigal has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of F.
2026-03-27 16:451mo ago
2026-03-27 12:361mo ago
Why Is Southwest Gas (SWX) Down 2.1% Since Last Earnings Report?
It has been about a month since the last earnings report for Southwest Gas (SWX - Free Report) . Shares have lost about 2.1% in that time frame, outperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Southwest Gas due for a breakout? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent catalysts for Southwest Gas Corporation before we dive into how investors and analysts have reacted as of late.
Southwest Gas' Fourth-Quarter Earnings & Revenues Miss Estimates
Southwest Gas Holdings Inc. recorded fourth-quarter 2025 operating earnings of $1.36 per share, which missed the Zacks Consensus Estimate of $1.40 by 2.9%. The bottom line also decreased from the year-ago quarter’s figure of $1.39.
SWX reported earnings of $3.65 per share for 2025 compared with $3.16 per share in 2024, which reflects a year-over-year increase of 15.5%.
SWX’s Total RevenuesOperating revenues totaled $0.48 billion, which lagged the Zacks Consensus Estimate of $0.58 billion by 17.7%. The top line also declined 62.2% from $1.27 billion reported in the prior-year quarter.
SWX reported total revenues of $1.94 billion for 2025 compared with $5.11 billion in 2024, which reflects a year-over-year decrease of 62%.
Highlights of SWX’s Earnings ReleaseOperations and maintenance expenses in 2025 totaled $544.1 million, up 3.3% from the year-ago figure of $526.7 million.
The total operating income in 2025 was $473.9 million, up 16.6% year over year.
Total system throughput in 2025 was 204.69 million dekatherms, down 6.7% from 219.43 million dekatherms reported in 2024.
Southwest Gas’ Financial HighlightsCash and cash equivalents, as of Dec. 31, 2025, were $576.6 million compared with $314.8 million as of Dec. 31, 2024.
The long-term debt, less current maturities, amounted to $3.43 billion as of Dec. 31, 2025, compared with $3.50 billion as of Dec. 31, 2024.
Southwest Gas’ net cash provided by operating activities for the year ended Dec. 31, 2025, was $0.56 billion compared with $1.36 billion in the year-ago period.
SWX’s 2026 GuidanceSouthwest Gas expects its 2026 earnings per share to be in the range of $4.17-$4.32. The Zacks Consensus Estimate is pegged at $4.13, lower than the company’s guided range.
The company expects a rate base compound annual growth rate of 9.5-11.5% in the 2026-2030 period.
The capital expenditure is projected at $1.25 billion for 2026, while total capital expenditure for the 2026-2030 timeframe is expected to reach $6.3 billion.
How Have Estimates Been Moving Since Then?Analysts were quiet during the last two month period as none of them issued any earnings estimate revisions.
VGM ScoresAt this time, Southwest Gas has a poor Growth Score of F, however its Momentum Score is doing a lot better with an A. However, the stock has a score of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook Southwest Gas has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.
2026-03-27 16:451mo ago
2026-03-27 12:361mo ago
Universal Health Services (UHS) Down 9.4% Since Last Earnings Report: Can It Rebound?
It has been about a month since the last earnings report for Universal Health Services (UHS - Free Report) . Shares have lost about 9.4% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Universal Health Services due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important catalysts.
Universal Health's Q4 Earnings Miss on Softer Volumes & Rising Costs
Universal Health reported fourth-quarter 2025 adjusted earnings per share (EPS) of $5.88, which missed the Zacks Consensus Estimate by 0.6%. The bottom line soared 19.5% year over year.
Net revenues of $4.49 billion improved 9.1% year over year. The top line beat the consensus mark by a whisker.
The quarterly results suffered from lower-than-expected admissions, adjusted patient days and elevated operating costs. The negatives were partially offset by higher net revenue per adjusted admissions.
UHS’ Quarterly Operational UpdateAdjusted EBITDA, net of NCI, rose 10.4% year over year to $678.7 million, but came lower than our estimate of $681 million.
Total operating costs came in at $3.97 billion, which escalated 9% year over year in the quarter under review due to higher salaries, wages and benefits, supplies and other operating expenses. The metric came higher than our estimate of $3.93 billion.
UHS’ Segmental UpdateAcute Care Hospital ServicesAdjusted admissions (adjusted for outpatient activity) remained flat on a same-facility basis in the fourth quarter, which missed our model estimate of 1.4% growth. Adjusted patient days declined 0.7% year over year, while net revenue per adjusted admission advanced 5.4%. Net revenues stemming from Universal Health’s acute care services improved 6.9% on a same-facility basis.
Behavioral Health Care ServicesAdjusted admissions inched up 1.8% on a same-facility basis, which was lower than estimated. Adjusted patient days rose 1.5%, while net revenue per adjusted patient days advanced 5.6%. Net revenues derived from UHS’ behavioral healthcare services improved 7.2% on a same-facility basis.
Financial Update of UHS (As of Dec. 31, 2025)Universal Health exited the fourth quarter with cash and cash equivalents of $137.8 million, which rose from the 2024-end level of $126 million. As part of its $1.3 billion revolving credit facility, net of outstanding borrowings and letters of credit, there remains an aggregate available borrowing capacity of $889 million at the fourth-quarter end. Total assets of $15.53 billion increased from the $14.47 billion figure at 2024-end.
Long-term debt amounted to $4 billion, which declined from $4.46 billion at 2024-end. Current maturities of long-term debt totaled $748.2 million.
Total equity of $7.34 billion advanced from the 2024-end figure of $6.75 billion.
UHS generated cash flows from operations of $1.86 billion for 2025, which slipped from the prior-year comparable period’s $2.07 billion.
UHS’ Share Repurchase UpdateUniversal Health bought back shares worth around $333.5 million in the fourth quarter and $899.3 million in 2025. The total remaining authorization available under the buyback program now stands at $1.4 billion.
2026 GuidanceManagement currently forecasts net revenues within $18.417-$18.789 billion. The mid-point of the guidance implies 7.1% growth from the 2025 figure of $17.365 billion.
Adjusted EBITDA, net of NCI, is anticipated to be in the range of $2.641-$2.789 billion in 2026, indicating a 4.8% growth from the 2025 level of $2.59 billion. EPS is presently expected in the band of $22.64-$24.52, the mid-point of which suggests 8.5% growth from the 2025 figure of $21.74.
Capital expenditures are expected to be between $950 million and $1.1 billion.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates revision.
VGM ScoresCurrently, Universal Health Services has a strong Growth Score of A, though it is lagging a bit on the Momentum Score front with a B. Charting a somewhat similar path, the stock has a grade of A on the value side, putting it in the top 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Universal Health Services has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
2026-03-27 16:451mo ago
2026-03-27 12:361mo ago
Why Is The Trade Desk (TTD) Down 9.2% Since Last Earnings Report?
It has been about a month since the last earnings report for The Trade Desk (TTD - Free Report) . Shares have lost about 9.2% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is The Trade Desk due for a breakout? Well, first let's take a quick look at the latest earnings report in order to get a better handle on the recent catalysts for The Trade Desk before we dive into how investors and analysts have reacted as of late.
Key HighlightsRevenue: $847 million in Q4, up 14% year over year; up 19% excluding political advertising. Revenues beat the Zacks Consensus Estimate by 0.6%.EPS: Adjusted diluted EPS was 59 cents, in line with the Zacks Consensus Estimate; GAAP diluted EPS was 39 cents.Profitability: Adjusted EBITDA of $400 million, nearly 47% margin in Q4 FY2025.Operating expenses: $590 million in Q4, up 8% year over year; excluding stock-based compensation, operating expenses were $478 million, up 15% year over year.Cash generation: Operating cash flow of $312 million and free cash flow of $282 million in Q4.Balance sheet: Approximately $1.3 billion in cash, cash equivalents and short-term investments at quarter end; no debt.Capital returns: Repurchased $423 million of shares in Q4; authorization increased to $500 million, inclusive of remaining capacity.Revenue drivers and vertical mixTop-line growth in the fourth quarter of 2025 benefited from continued strength in CTV and audio. Management highlighted that CTV outgrew the company average through 2025 and again in the fourth quarter, even while lapping elevated political spend in the prior year. Audio represented about 6% of business in the quarter and was the fastest-growing channel year over year. On the flip side, CPG and, to a lesser extent, auto remained the softest verticals entering the fourth quarter and into the early first quarter of 2026, reflecting tariff uncertainty, uneven volumes, and consumer cost-of-living pressures that began in mid-2025. Offsets came from medical/health, technology, and business and finance verticals, where spending expanded solidly.
Channel and geographic mixVideo, which includes CTV, represented roughly 50% of fourth quarter activity and continued to accrete to the mix. Mobile was approximately 30% of the share and display was a low double-digit percentage. The United States comprised 84% of revenue, with international at 16%. Growth in EMEA and APAC outpaced North America, consistent with the company's investment focus in those regions.
Margins, expenses, and operating disciplineFourth quarter adjusted EBITDA margin was about 47%, underscoring strong unit economics amid ongoing reinvestment. Operating expenses rose 8% year over year, or 15% excluding stock-based compensation, reflecting increased platform operations and continued product innovation. Management reiterated that headcount growth remained below revenue growth for the third straight year in 2025, supporting operating discipline. Days sales outstanding were nearly 100 days and days’ payable outstanding were under 85 days, consistent with recent periods.
Cash flow, liquidity, and capital deploymentCash generation remained robust with $312 million in operating cash flow and $282 million in free cash flow. Liquidity stood at about $1.3 billion in cash, cash equivalents and short-term investments at the quarter-end, and the company reported no debt. Share repurchases totaled $423 million in the fourth quarter, and the authorization was increased to $500 million, inclusive of remaining capacity, with plans to continue opportunistic buybacks and offset employee stock dilution.
Management commentaryManagement characterized the fourth quarter as a solid finish to 2025, with reported revenue growth of 14% year over year, or nearly 19% excluding political. Across 2025, revenue growth decelerated from 25% in the first quarter to 19% in the second quarter, 18% in the third quarter, and 14% in the fourth quarter on a reported basis, as CPG and auto headwinds intensified through the year. Even so, full-year revenue reached $2.9 billion (up 18% year over year) on roughly $13.4 billion of spend, and adjusted EBITDA expanded in line with revenue growth. CTV remained one of the fastest-growing channels, and international momentum in EMEA and APAC continued to outstrip North America.
Near-term outlook and 2026 investment postureFor the first quarter of 2026, management guided to revenue of at least $678 million (up 10% year over year) and adjusted EBITDA of approximately $195 million. The first quarter margin profile is expected to reflect timing related to infrastructure spend as the company completes its transition to owned data centers. For 2026, the adjusted EBITDA margin percentage is expected to be approximately in line with 2025, with 2026 framed as a disciplined investment year focused on AI capabilities and infrastructure. Headcount growth is planned to remain below revenue growth.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in estimates review.
The consensus estimate has shifted -17.59% due to these changes.
VGM ScoresCurrently, The Trade Desk has a average Growth Score of C, however its Momentum Score is doing a bit better with a B. Following the exact same course, the stock has a grade of B on the value side, putting it in the top 40% for value investors.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, The Trade Desk has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerThe Trade Desk is part of the Zacks Internet - Services industry. Over the past month, Akamai Technologies (AKAM - Free Report) , a stock from the same industry, has gained 17.4%. The company reported its results for the quarter ended December 2025 more than a month ago.
Akamai Technologies reported revenues of $1.09 billion in the last reported quarter, representing a year-over-year change of +7.4%. EPS of $1.84 for the same period compares with $1.66 a year ago.
For the current quarter, Akamai Technologies is expected to post earnings of $1.64 per share, indicating a change of -3.5% from the year-ago quarter. The Zacks Consensus Estimate has changed +0.1% over the last 30 days.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Akamai Technologies. Also, the stock has a VGM Score of D.
2026-03-27 16:451mo ago
2026-03-27 12:361mo ago
Why Is TJX (TJX) Down 0.7% Since Last Earnings Report?
A month has gone by since the last earnings report for TJX (TJX - Free Report) . Shares have lost about 0.7% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is TJX due for a breakout? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent catalysts for The TJX Companies, Inc. before we dive into how investors and analysts have reacted as of late.
TJX Q4 Earnings and Revenues Beat Estimates, Sales Increase 9% Y/YThe TJX Companies posted fourth-quarter fiscal 2026 results, wherein the top and bottom lines beat the Zacks Consensus Estimate. Both metrics also increased from the year-ago quarter.
TJX's Quarterly Metrics: Key InsightsThe TJX Companies’ earnings per share (EPS) were $1.43, up 16% from the year-ago quarter. The metric also beat the Zacks Consensus Estimate of $1.38 per share.
Net sales came in at $17,743 million, registering an increase of 9% year over year and surpassing the Zacks Consensus Estimate of $17,453 million.
In the Marmaxx (the United States) division, the company’s net sales were $10,655 million, up 7% year over year. Net sales amounted to $3,093 million, up 8% year over year, in the HomeGoods (the United States) division. TJX Canada’s net sales were $1,612 million, up 11% from the figure reported in the year-ago period. TJX International’s (Europe & Australia) net sales were $2,383 million, up 15% year over year.
The company witnessed a 5% jump in consolidated comparable store sales, supported by strong performance in every division. Comparable store sales rose 5% at Marmaxx (the United States), 6% at HomeGoods (the United States), 7% at TJX Canada and 4% at TJX International (Europe & Australia).
The TJX Companies’ adjusted pretax profit margin was 12.2%, up 0.6 percentage points from the year-ago quarter’s level. The increase is driven by lower-than-expected inventory shrink expenses and operating leverage from stronger-than-planned sales. These gains were partially offset by elevated incentive compensation accruals.
The adjusted gross profit margin was 31.1%, up 0.6 percentage points year over year, mainly driven by an elevated merchandise margin and expense leverage on strong sales growth. These gains were partially offset by unfavorable inventory hedges.
The company’s adjusted selling, general and administrative costs, as a percent of sales, were 19.1%, a 0.1 percentage point decrease.
TJX’s Financial Health SnapshotIn fiscal 2026, the company increased its total store count by 129, reaching 5,214.
The TJX Companies ended the quarter with cash and cash equivalents of $6.2 billion, long-term debt of $1.9 billion and shareholders’ equity of $10.2 billion. It generated an operating cash flow of $6.9 billion in fiscal 2026.
In the fiscal fourth quarter, the company returned $1.26 billion to shareholders, including $784 million used to repurchase 5.1 million of its shares and $472 million paid in dividends. For fiscal 2026, the company returned a total of $4.3 billion to its shareholders, repurchasing 18.5 million shares for $2.5 billion and distributing $1.8 billion in dividends. The company announced its intention to increase the regular quarterly dividend on its common stock to 48 cents per share. The dividend is expected to be declared in March and paid in June 2026, representing a 13% increase over the most recent quarterly dividend.
It also announced plans to repurchase approximately $2.50 billion to $2.75 billion of TJX stock in the fiscal year ending Jan. 30, 2027. With $1.1 billion remaining under its existing authorization at the end of fiscal 2026, the board approved a new stock repurchase program authorizing up to an additional $3 billion in share repurchases from time to time.
What to Expect From TJX Moving Forward?For fiscal 2027, the company projects consolidated comparable sales growth of 2% to 3%, a pretax profit margin of 11.7% to 11.8% and earnings per share in the range of $4.93 to $5.02.
For the first quarter of fiscal 2027, the company expects consolidated comparable sales to increase 2% to 3%, a pretax profit margin in the range of 10.3% to 10.4% and earnings per share of 97 cents to 99 cents.
How Have Estimates Been Moving Since Then?It turns out, estimates review flatlined during the past month.
VGM ScoresCurrently, TJX has a great Growth Score of A, though it is lagging a lot on the Momentum Score front with an F. Charting a somewhat similar path, the stock has a score of D on the value side, putting it in the bottom 40% for value investors.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook TJX has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
2026-03-27 16:451mo ago
2026-03-27 12:361mo ago
Teladoc (TDOC) Up 3.2% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for Teladoc (TDOC - Free Report) . Shares have added about 3.2% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Teladoc due for a pullback? Well, first let's take a quick look at the latest earnings report in order to get a better handle on the recent drivers for Teladoc Health, Inc. before we dive into how investors and analysts have reacted as of late.
Teladoc Tops Q4 Earnings Estimates on International Growth & Lower Costs
Teladoc Health reported a fourth-quarter 2025 adjusted loss of 14 cents per share, narrower than the Zacks Consensus Estimate of a loss of 19 cents.
The company posted a loss of 28 cents in the year-ago quarter.
Operating revenues increased 0.3% year over year to $642.3 million and beat the Zacks Consensus Estimate by 1.3%.
The quarterly results benefited from strong international growth, solid Integrated Care performance and lower expenses. However, lower access fee revenues, a decline in U.S. revenues and weakness in the BetterHelp segment partly offset the upside.
Full-Year 2025 Performance of TDOCOperating loss of $1.14 per share marked an improvement from the year-ago loss of $5.87.
Operating revenues declined 1.5% year over year to $2.5 billion. Total expenses fell 22.2% year over year to $2.8 billion.
Adjusted EBITDA decreased 9.5% year over year to $281.1 million.
Q4 Operational Update of Teladoc HealthRevenues from access fees totaled $521.6 million, down 4% year over year. The figure missed the Zacks Consensus Estimate of $536.2 million as well as our estimate of $528.9 million. Other revenues increased 24% year over year to $120.7 million. The metric surpassed the Zacks Consensus Estimate of $94.3 million and our estimate of $103.8 million.
On a geographical basis, Teladoc Health generated $517.3 million in revenues from the United States, down 3% year over year. The metric lagged the Zacks Consensus Estimate of $523 million. International revenues of $125 million advanced 19% year over year in the quarter under review and surpassed the consensus mark of $109.7 million.
Adjusted EBITDA rose 12% year over year to $83.8 million and beat our estimate of around $77 million. Total costs and expenses of $678.3 million declined 1.5% year over year and were below our estimate of $679.3 million. The year-over-year decrease was primarily due to lower advertising and marketing, technology and development, and sales expenses.
TDOC: Q4 Segmental UpdateThe Integrated Care segment’s revenues increased 5% year over year to $409.1 million in the reported quarter. The figure beat the Zacks Consensus Estimate of $400.1 million and our estimate of $396.2 million. Adjusted EBITDA rose 23% year over year to $65.3 million and surpassed the consensus mark of $64.3 million. The adjusted EBITDA margin expanded 240 basis points (bps) year over year to 16%.
The BetterHelp segment generated revenues of $229.1 million, down 6% year over year. The metric missed the Zacks Consensus Estimate of $230.6 million as well as our estimate of $236.5 million. Adjusted EBITDA declined 15% year over year to $18.5 million. The figure surpassed the consensus mark of $15.4 million. The adjusted EBITDA margin of 7.9% contracted 80 bps year over year.
Visits & Memberships of Teladoc HealthTotal visits to Teladoc Health were 4.3 million in the fourth quarter, down 1% year over year. The metric also missed the Zacks Consensus Estimate by 1.1%.
U.S. Integrated Care members totaled 101.8 million, up 9% year over year. However, the figure missed the consensus mark by 0.5%.
TDOC’s Financial Update (As of Dec. 31, 2025)Teladoc Health exited 2025 with cash and cash equivalents of $781.1 million, down from $1.3 billion as of 2024-end.
Total assets decreased to $2.9 billion from $3.5 billion at the end of 2024.
Debt totaled $994.9 million, up from $991.4 million as of 2024-end.
Total stockholders’ equity declined to $1.4 billion from $1.5 billion as of Dec. 31, 2024.
In 2025, TDOC generated net cash from operations of $294.4 million, flat year over year. Free cash flow amounted to $166.9 million, down 2% year over year.
Teladoc Health’s Q1 2026 OutlookRevenues in the Integrated Care segment are forecasted to witness year-over-year growth in the range of (1.20)-2.00%. The unit’s adjusted EBITDA margin is anticipated to be in the band of 12.5-14%. U.S. Integrated Care members are expected to be between 99 million and 100 million.
Revenues in the BetterHelp segment are estimated to register a 7-11.25% year-over-year decline. The segment’s adjusted EBITDA margin is anticipated to be in the band of 0.75-2.75%.
Total revenues are expected to be between $598 million and $620 million. Adjusted EBITDA is anticipated to be between $50 million and $62 million. Net loss per share is estimated to be between 35 cents and 45 cents.
Teladoc Health’s 2026 OutlookRevenues in the Integrated Care segment are expected to witness 0.4-3.9% growth on a year-over-year basis. U.S. Integrated Care members are projected to be in the band of 97-100 million. The adjusted EBITDA margin in the segment is forecasted to be in the range of 15.1-16.1%.
Revenues in the BetterHelp segment are anticipated to record a year-over-year decline of 0.5-7%. The adjusted EBITDA margin in the segment is estimated to be between 3% and 4.6%.
The company expects 2026 revenues to be in the $2.470-$2.587 billion range. Adjusted EBITDA is guided at $266-$308 million. Net loss per share is estimated to be in the $0.70-$1.10 range.
Free cash flow is currently projected to be in the $130-$170 million band for 2026.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a downward trend in estimates review.
The consensus estimate has shifted -9.21% due to these changes.
VGM ScoresAt this time, Teladoc has a strong Growth Score of A, though it is lagging a lot on the Momentum Score front with a C. Charting a somewhat similar path, the stock was allocated a grade of B on the value side, putting it in the second quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Teladoc has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerTeladoc is part of the Zacks Medical Services industry. Over the past month, Pediatrix Medical Group (MD - Free Report) , a stock from the same industry, has gained 5.6%. The company reported its results for the quarter ended December 2025 more than a month ago.
Pediatrix Medical Group reported revenues of $493.77 million in the last reported quarter, representing a year-over-year change of -1.7%. EPS of $0.50 for the same period compares with $0.51 a year ago.
For the current quarter, Pediatrix Medical Group is expected to post earnings of $0.37 per share, indicating a change of +12.1% from the year-ago quarter. The Zacks Consensus Estimate has changed +2.3% over the last 30 days.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Pediatrix Medical Group. Also, the stock has a VGM Score of A.
2026-03-27 16:451mo ago
2026-03-27 12:381mo ago
Meta stock selloff continues, but a bigger risk looms
Shares of Meta Platforms extended their selloff on Friday, as mounting legal setbacks weighed on investor sentiment, but the recent decline also points to a deeper concern building beneath the surface.
While US court verdicts have triggered immediate losses, investors are increasingly focused on the broader implications for Meta’s business model and future risk profile.
The stock dropped following rulings in New Mexico and Los Angeles that found the company responsible for harm to teenage users.
The decisions included a $375 million fine, along with the potential for additional damages tied to mental health claims.
While the immediate financial impact of the individual cases is limited, investors are increasingly focused on the broader implications.
Legal experts have warned that these rulings could pave the way for litigation targeting platform design rather than user-generated content.
Such a shift could bypass existing legal protections and expose the company to a growing number of similar lawsuits already filed in US courts.
“There was much discussion…whether the ruling can be compared to those against Big Tobacco in the 90’s,” wrote JP Morgan analyst Doug Anmuth. “[A]n appeal lies ahead, along with many other cases going to trial. But the noise could keep Meta shares under pressure or range-bound in the near-term.”
The company is appealing the rulings, but the evolving legal landscape has added uncertainty to its outlook, contributing to the recent decline in its share price.
AI spending surge raises concerns over cash flowBeyond legal risks, investor sentiment has also been weighed down by Meta’s aggressive spending on artificial intelligence infrastructure.
The company has committed substantial capital to expanding its data center footprint and advancing its AI capabilities.
Meta recently increased its planned investment in a data center in El Paso, Texas, to more than $10 billion, up from an earlier estimate of $1.5 billion.
This is part of a broader strategy that includes 31 planned data center projects across the United States.
“We are increasing our investment in El Paso to more than $10 billion and will now support more than 300 jobs at the data center once completed,” Meta said in a statement. “Our construction needs will also grow and we now anticipate that over 4,000 construction workers will be on-site at the peak of construction.”
The company has also agreed to fund seven natural gas power plants and related infrastructure in Louisiana to support another major data center project.
These investments come at a cost.
Meta has flagged up to $135 billion in capital expenditure this year, with free cash flow expected to fall sharply to $6.25 billion from $43.80 billion in 2025, according to FactSet data.
Unlike some peers, Meta lacks a cloud-computing business to offset these costs, leaving it reliant on its core operations to justify the spending.
Concerns have also emerged around its ability to compete in the rapidly evolving AI space, with reports suggesting delays in the release of its latest model.
“We continue to see Meta as range bound until a competitive new model is launched or more clarity [comes] around free cash flow,” wrote Oppenheimer analyst Jason Helfstein.
Investors weigh risks as stock trends lower Meta shares dropped 3% on Friday. The stock has now fallen 12% in the last 5 trading sessions.
The company’s market position has also shifted, with Meta slipping to the eighth-largest US company by market capitalization, behind firms such as Broadcom and Tesla.
Investor caution is also reflected in portfolio moves.
Cathie Wood’s ARK Invest sold 3,578 Meta shares across three funds, worth about $2.1 million based on Wednesday's closing price.
The ARK Innovation ETF now holds around 105,000 Meta shares, representing roughly 1% of the fund’s weighting.
Despite these challenges, Meta continues to benefit from solid advertising performance, which supported its most recent earnings.
However, the combination of rising legal risks, heavy AI spending, and uncertainty around future innovation has kept investors on edge.
As the company navigates these headwinds, market participants are likely to remain focused on developments in ongoing legal cases, progress in AI initiatives, and the trajectory of its cash flow in the coming quarters.
2026-03-27 16:451mo ago
2026-03-27 12:401mo ago
SOLV or HQY: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical Services sector have probably already heard of Solventum (SOLV) and HealthEquity (HQY). But which of these two stocks presents investors with the better value opportunity right now?
2026-03-27 16:451mo ago
2026-03-27 12:401mo ago
JHG or CNS: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Financial - Investment Management sector might want to consider either Janus Henderson Group plc (JHG) or Cohen & Steers Inc (CNS). But which of these two stocks is more attractive to value investors?
2026-03-27 16:451mo ago
2026-03-27 12:401mo ago
DTI vs. CLB: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Oil and Gas - Field Services sector have probably already heard of Drilling Tools International Corp. (DTI - Free Report) and Core Laboratories (CLB - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revision trends, while our Style Scores work to grade companies based on specific traits.
Currently, Drilling Tools International Corp. has a Zacks Rank of #1 (Strong Buy), while Core Laboratories has a Zacks Rank of #3 (Hold). The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that DTI has an improving earnings outlook. But this is only part of the picture for value investors.
Value investors also try to analyze a wide range of traditional figures and metrics to help determine whether a company is undervalued at its current share price levels.
The Value category of the Style Scores system identifies undervalued companies by looking at a number of key metrics. These include the long-favored P/E ratio, P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that help us determine a company's fair value.
DTI currently has a forward P/E ratio of 18.95, while CLB has a forward P/E of 20.92. We also note that DTI has a PEG ratio of 2.11. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. CLB currently has a PEG ratio of 14.33.
Another notable valuation metric for DTI is its P/B ratio of 1.03. The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total liabilities. For comparison, CLB has a P/B of 2.81.
Based on these metrics and many more, DTI holds a Value grade of B, while CLB has a Value grade of C.
DTI sticks out from CLB in both our Zacks Rank and Style Scores models, so value investors will likely feel that DTI is the better option right now.
2026-03-27 16:451mo ago
2026-03-27 12:401mo ago
DAR vs. MDLZ: Which Stock Is the Better Value Option?
Investors interested in stocks from the Food - Miscellaneous sector have probably already heard of Darling Ingredients (DAR - Free Report) and Mondelez (MDLZ - Free Report) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores highlight stocks with specific traits.
Currently, Darling Ingredients has a Zacks Rank of #2 (Buy), while Mondelez has a Zacks Rank of #3 (Hold). This means that DAR's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. But this is just one factor that value investors are interested in.
Value investors also tend to look at a number of traditional, tried-and-true figures to help them find stocks that they believe are undervalued at their current share price levels.
The Style Score Value grade factors in a variety of key fundamental metrics, including the popular P/E ratio, P/S ratio, earnings yield, cash flow per share, and a number of other key stats that are commonly used by value investors.
DAR currently has a forward P/E ratio of 17.68, while MDLZ has a forward P/E of 18.97. We also note that DAR has a PEG ratio of 0.43. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. MDLZ currently has a PEG ratio of 2.40.
Another notable valuation metric for DAR is its P/B ratio of 1.94. The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total liabilities. For comparison, MDLZ has a P/B of 2.85.
These are just a few of the metrics contributing to DAR's Value grade of B and MDLZ's Value grade of C.
DAR has seen stronger estimate revision activity and sports more attractive valuation metrics than MDLZ, so it seems like value investors will conclude that DAR is the superior option right now.
2026-03-27 16:451mo ago
2026-03-27 12:401mo ago
GBOOY vs. BAM: Which Stock Should Value Investors Buy Now?
Investors interested in Financial - Miscellaneous Services stocks are likely familiar with Grupo Financiero Banorte SAB de CV (GBOOY - Free Report) and Brookfield Asset Management (BAM - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.
Grupo Financiero Banorte SAB de CV has a Zacks Rank of #2 (Buy), while Brookfield Asset Management has a Zacks Rank of #3 (Hold) right now. The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that GBOOY has an improving earnings outlook. But this is just one piece of the puzzle for value investors.
Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels.
Our Value category highlights undervalued companies by looking at a variety of key metrics, including the popular P/E ratio, as well as the P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that have been used by value investors for years.
GBOOY currently has a forward P/E ratio of 8.16, while BAM has a forward P/E of 23.12. We also note that GBOOY has a PEG ratio of 1.01. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. BAM currently has a PEG ratio of 1.46.
Another notable valuation metric for GBOOY is its P/B ratio of 2.14. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, BAM has a P/B of 8.03.
These are just a few of the metrics contributing to GBOOY's Value grade of A and BAM's Value grade of D.
GBOOY has seen stronger estimate revision activity and sports more attractive valuation metrics than BAM, so it seems like value investors will conclude that GBOOY is the superior option right now.
2026-03-27 16:451mo ago
2026-03-27 12:401mo ago
TTDKY or TEL: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Electronics - Miscellaneous Components sector might want to consider either TDK Corp. (TTDKY) or TE Connectivity (TEL). But which of these two stocks presents investors with the better value opportunity right now?
2026-03-27 16:451mo ago
2026-03-27 12:401mo ago
MG vs. GRMN: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Electronics - Miscellaneous Products sector might want to consider either Mistras (MG - Free Report) or Garmin (GRMN - Free Report) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores highlight stocks with specific traits.
Right now, both Mistras and Garmin are sporting a Zacks Rank of #1 (Strong Buy). This means that both companies have witnessed positive earnings estimate revisions, so investors should feel comfortable knowing that both of these stocks have an improving earnings outlook. But this is just one piece of the puzzle for value investors.
Value investors also tend to look at a number of traditional, tried-and-true figures to help them find stocks that they believe are undervalued at their current share price levels.
Our Value category highlights undervalued companies by looking at a variety of key metrics, including the popular P/E ratio, as well as the P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that have been used by value investors for years.
MG currently has a forward P/E ratio of 14.39, while GRMN has a forward P/E of 25.12. We also note that MG has a PEG ratio of 0.90. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. GRMN currently has a PEG ratio of 2.83.
Another notable valuation metric for MG is its P/B ratio of 2.02. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, GRMN has a P/B of 5.06.
These metrics, and several others, help MG earn a Value grade of A, while GRMN has been given a Value grade of F.
Both MG and GRMN are impressive stocks with solid earnings outlooks, but based on these valuation figures, we feel that MG is the superior value option right now.
2026-03-27 16:451mo ago
2026-03-27 12:401mo ago
EBKDY or BMA: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Banks - Foreign sector might want to consider either Erste Group Bank AG (EBKDY) or Banco Macro (BMA). But which of these two companies is the best option for those looking for undervalued stocks?
2026-03-27 16:451mo ago
2026-03-27 12:401mo ago
SoFi's Galileo Integration: A Key Engine Behind Its Fintech Expansion
Key Takeaways SoFi integrated Galileo after its 2020 acquisition, powering BNPL services and AI-driven engagement tools.SOFI embeds Galileo directly into its roadmap, speeding innovation across digital banking and lending.SoFi's scale and user insights help Galileo refine its platform and expand capabilities. Since acquiring Galileo Financial Technologies in 2020, SoFi Technologies, Inc. (SOFI - Free Report) has meaningfully strengthened its fintech foundation by embedding Galileo’s payment-processing and technology capabilities throughout its expanding ecosystem. Galileo now supports key functions such as buy now, pay later services and AI-powered customer engagement tools, serving as a crucial layer behind SoFi’s seamless, technology-first user experience.
Operating within the same corporate structure has enabled significantly deeper integration. SoFi can integrate Galileo’s infrastructure directly into its product roadmap, bypassing the delays and constraints often associated with external partnerships. This alignment enhances speed to market, boosts operational efficiency and strengthens SoFi’s capacity to innovate across digital banking, lending and personal finance solutions. The relationship also creates a beneficial feedback cycle.
While Galileo powers SoFi’s offerings, it also benefits from SoFi’s scale and user insights, allowing it to refine its platform and broaden capabilities for its wider client network. Ultimately, the acquisition has become a core strategic advantage, positioning SoFi as a more vertically integrated fintech platform with greater control over both the customer experience and the underlying technology that supports it.
Other Fintech Stocks Worth WatchingBlock (XYZ - Free Report) , Robinhood (HOOD - Free Report) and PayPal (PYPL - Free Report) remain three fintech players worth monitoring. Block continues to deepen its ecosystem through Cash App and Square, aiming to connect consumer and merchant services more closely. Robinhood is gradually moving beyond trading into broader financial services, with its user base expanding steadily. Meanwhile, PayPal is focusing on strengthening branded checkout while enhancing Venmo’s functionality. Block, Robinhood and PayPal all face competitive pressures, yet they continue innovating across digital payment infrastructure and customer engagement strategies.
SOFI’s Price Performance, Valuation & EstimatesThe stock has declined 39% year to date compared with the industry’s 17% fall.
Image Source: Zacks Investment Research
From a valuation standpoint, SOFI trades at a forward price-to-earnings ratio of 24.38, well above the industry’s 9.15. It carries a Value Score of F.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for SOFI’s 2026 earnings has been on the rise over the past 60 days.
SOFI stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
2026-03-27 15:451mo ago
2026-03-27 11:251mo ago
Kalshi CEO Says Gambling Lawsuits Have Been Good for Prediction Markets
Hod Hasharon, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- Allot (NASDAQ: ALLT) (TASE: ALLT), a leading global provider of innovative Security-as-a-Service (SECaaS) and Deep Network Intelligence solutions for communication service providers and enterprises, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission ("SEC").
The annual report on Form 20-F, which contains its audited financial statements, can be accessed on the SEC's website at http://www.sec.gov as well as on the Company's investor relations website at https://investors.allot.com/financial-information/sec-filings. The Company will deliver a hard copy of its annual report on Form 20-F, including its complete audited financial statements, free of charge, to its shareholders upon request to [email protected].
###
About Allot
Allot Ltd. (NASDAQ: ALLT, TASE: ALLT) is a provider of leading innovative converged cybersecurity solutions and network intelligence for service providers and enterprises worldwide, enhancing value to their customers. Our solutions are deployed globally for network-native cybersecurity services, network and application analytics, traffic control and shaping, and more. Allot’s multi-service platforms are deployed by over 500 mobile, fixed and cloud service providers and over 1000 enterprises. Our industry-leading network-native security-as-a-service solution is already used by many millions of subscribers globally.
Forward-Looking Statement
This release contains forward-looking statements, which express the current beliefs and expectations of Company management. Such statements involve a number of known and unknown risks and uncertainties that could cause our future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied in such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our accounts receivables, including our ability to collect outstanding accounts and assess their collectability on a quarterly basis; our ability to meet expectations with respect to our financial guidance and outlook; our ability to compete successfully with other companies offering competing technologies; the loss of one or more significant customers; consolidation of, and strategic alliances by, our competitors; government regulation; the timing of completion of key project milestones which impact the timing of our revenue recognition; lower demand for key value-added services; our ability to keep pace with advances in technology and to add new features and value-added services; managing lengthy sales cycles; operational risks associated with large projects; our dependence on channel partners for a material portion of our revenues; and other factors discussed under the heading "Risk Factors" in the Company's annual report on Form 20-F filed with the Securities and Exchange Commission. Forward-looking statements in this release are made pursuant to the safe harbor provisions contained in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made only as of the date hereof, and the company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.
Contango Ore, Inc. (CTGO) M&A Call March 26, 2026 1:00 PM EDT
Company Participants
Rick Van Nieuwenhuyse - President, CEO & Director
Shawn Khunkhun - President, CEO & Director
Conference Call Participants
Romeo Maione - 6ix
Presentation
Romeo Maione
6ix
So say good morning, good afternoon or good evening, depending on where in the world you're sending in from. I think almost every time zone is represented in today's audience, there are quite a few of you. So really, thank you so much for joining us. I couldn't be more excited to have with me today, Rick Van Nieuwenhuyse, CEO of Contango Silver and Gold; and Shawn Khunkhun, the company's President.
Gentlemen, how are you today?
Rick Van Nieuwenhuyse
President, CEO & Director
Excellent. Just excited to get going here.
Shawn Khunkhun
President, CEO & Director
Me too.
Romeo Maione
6ix
Awesome. And as we go through what I always describe as the most boring part of a webinar where I tell you what's going on, you can also look at Contango's fancy new branding. So, I'll throw that up while I do this.
A couple of things I wanted to talk about today. There are a lot of questions that came in already. So that chat button at the bottom of your screen, we are in interactive event.
Please do ask questions during today's event. I will try to get to as many as I can, but I warn you, there is no way we will get to every question that was asked. So if your question does not come up, that you submitted over e-mail or that you submit in chat, I will be sending it to the Contango Silver and Gold team, so they'll be able to tackle it afterwards.
But I'm going to try to get
2026-03-27 15:451mo ago
2026-03-27 11:251mo ago
PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript
PAVmed Inc. (PAVM) Shareholder/Analyst Call March 27, 2026 10:00 AM EDT
Company Participants
Lishan Aklog - Chairman & CEO
Michael Gordon - Executive VP, General Counsel & Secretary
Conference Call Participants
Eric Schwartz
Alwyn Burton
Presentation
Lishan Aklog
Chairman & CEO
I call the Special Meeting of Stockholders of PAVmed Inc. to order. I am Lishan Aklog, the company's Chairman and Chief Executive Officer. Also present are Dennis McGrath, the company's President and Chief Financial Officer; Michael Gordon, the company's General Counsel; Eric Schwartz of Graubard Miller, outside Counsel of the company; and Alwyn Burton of Continental Stock Transfer & Trust Company, the company's transfer agent. Eric will act as the Secretary of the meeting. As you all know, we're holding this special meeting via live webcast. To help the meeting run smoothly, Mr. Gordon will review a couple of housekeeping items before we begin.
Michael Gordon
Executive VP, General Counsel & Secretary
Thanks, Lishan. First, until the polls are closed towards the end of the meeting, you will have an opportunity to vote through the webcast platform. If you wish to vote, simply click on the voting link and follow the instructions. Voting through the webcast platform will revoke any previously delivered proxy. Second, during the meeting, you will have the opportunity to submit questions to management. You may submit questions through the questions pane in the webcast platform. We will review these questions and if appropriate, we'll respond to them after the meeting. Third, during the meeting, you may view a list of stockholders of record as of the close of business on the record date as certified by Continental Stock Transfer & Trust Company. Simply click on the corresponding link in the webcast platform.
Lishan Aklog
Chairman & CEO
With those matters addressed, we will now proceed to the
2026-03-27 15:451mo ago
2026-03-27 11:261mo ago
Carnival (CCL) Tops Q1 Earnings and Revenue Estimates
Carnival (CCL - Free Report) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.13 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +14.29%. A quarter ago, it was expected that this cruise operator would post earnings of $0.25 per share when it actually produced earnings of $0.34, delivering a surprise of +36%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Carnival, which belongs to the Zacks Leisure and Recreation Services industry, posted revenues of $6.17 billion for the quarter ended February 2026, surpassing the Zacks Consensus Estimate by 0.97%. This compares to year-ago revenues of $5.81 billion. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Carnival shares have lost about 17.2% since the beginning of the year versus the S&P 500's decline of 5.4%.
What's Next for Carnival?While Carnival has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Carnival was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.42 on $6.66 billion in revenues for the coming quarter and $2.37 on $27.81 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Leisure and Recreation Services is currently in the bottom 40% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Travel + Leisure Co. (TNL - Free Report) , has yet to report results for the quarter ended March 2026.
This company is expected to post quarterly earnings of $1.30 per share in its upcoming report, which represents a year-over-year change of +17.1%. The consensus EPS estimate for the quarter has been revised 0.9% higher over the last 30 days to the current level.
Travel + Leisure Co.'s revenues are expected to be $950.53 million, up 1.8% from the year-ago quarter.
2026-03-27 15:451mo ago
2026-03-27 11:261mo ago
Globe Life Trades Above 200-Day SMA: Time to Buy the Stock?
Key Takeaways Globe Life revenues are rising on strong life and health premium growth and improving net investment income. Globe Life expects solid 2026 sales growth across American Income, Liberty National and health segments. Globe Life's strong liquidity and capital position support buybacks and a dividend raised 22.2% in Feb 2026. Globe Life Inc. (GL - Free Report) has been trading above its 200-day simple moving average (SMA), signaling a short-term bullish trend. Its share price as of Wednesday was $138.80, down 9.1% from its 52-week high of $152.71.
The 200-day SMA is a long-term technical indicator that averages a stock's closing price over the last 200 trading days to smooth out volatility and identify the broader trend direction. When the stock price crosses above the 200-day SMA, it can be a signal to buy or hold.
Image Source: Zacks Investment Research
GL Shares are AffordableGlobe Life shares are trading at a discount compared to the industry. Its forward price-to-earnings multiple of 8.91X is lower than the industry average of 11.92X, the Finance sector’s 15.25X and the Zacks S&P 500 Composite’s 20.8X. Also, it has a Value Score of A.
Shares of other insurers like Unum Group (UNM - Free Report) are also trading at a discount to the industry average, while AMERISAFE, Inc. (AMSF - Free Report) and Aflac Incorporated (AFL - Free Report) are trading at a multiple.
Image Source: Zacks Investment Research
GL’s Price PerformanceGlobe Life shares have gained 5.6% in the past year against the industry’s decline of 4.7%.
Image Source: Zacks Investment Research
GL’s Growth Projection EncouragesThe Zacks Consensus Estimate for Globe Life’s 2026 earnings per share indicates a year-over-year increase of 5.2%. The consensus estimate for 2025 revenues is pegged at $6.38 billion, implying a year-over-year improvement of 5.9%. The consensus estimate for 2027 earnings per share and revenues indicates an increase of 8.1% and 5.6%, respectively, from the corresponding 2026 estimates.
Earnings have grown 16.1% in the past five years, better than the industry average of 0.6%.
Target Price Reflects Potential UpsideBased on short-term price targets offered by 12 analysts, the Zacks average price target is $170.50 per share. The average indicates a potential 23.99% upside from the last closing price.
Image Source: Zacks Investment Research
GL’s Return on CapitalGL’s trailing 12-month return on equity is 21.3%, ahead of the industry average of 14.3%. Return on equity, a profitability measure, reflects how effectively a company is utilizing its shareholders’ equity.
Also, the return on invested capital (ROIC) in the trailing 12 months was 12.6%, better than the industry average of 6.8%. Its ROIC has been increasing over the last few quarters amid capital investment made over the same time frame. This reflects the company’s efficiency in utilizing funds to generate income.
Key Points to Note for Globe LifeGlobe Life has been witnessing a positive trend in revenues, driven by premium growth in its Life Insurance and Health Insurance segments and net investment income.
The strong performance of the American Income and Liberty National divisions should drive the top line in the future. Liberty National is likely to continue to benefit from improved productivity and agent count. GL’s expansion initiatives to capture heavily populated and less penetrated areas should drive growth in the future.
Globe Life expects net life sales of high single-digit growth at American Income, low double-digit growth at Liberty National, and mid-single digit growth at direct-to-consumer in 2026. The company expects Net health sales of low double-digit growth for both Liberty National and Family Heritage in 2026. For United American, the company is currently projecting flat sales growth for 2026.
Moreover, net investment income continues to be another important driver of the company’s top-line growth and has been exhibiting improvement over the last few years. The metric is likely to keep growing, riding on improved invested assets and higher interest rates on new investments.
The company has maintained a strong liquidity position with sufficient cash-generation capabilities. Its operations comprise writing basic protection life and supplemental health insurance policies, which generate strong and stable cash flows. For 2026, Global Life targets a consolidated company action level RBC ratio in the range of 300% to 320%.
A strong capital position enables Globe Life to enhance its shareholder value via share buybacks and dividend payouts. The insurer has also increased its dividend at a 9.2% CAGR from 2017 to 2026. In February 2026, it hiked its dividend by 22.2%
End NotesGlobe Life’s higher life and health sales, improved invested assets, increased productivity and agent count, strong liquidity position and effective capital deployment make it an attractive stock.
Its solid growth projections as well as attractive valuations are other positives. Coupled with a higher average price target and favorable return on capital, the time appears right for potential investors to bet on this Zacks Rank #2 (Buy) insurer. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Alerian MLP ETF (AMLP - Free Report) is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has moved up 23.5% from its 52-week low price of $43.75 per share.
Are more gains in store for this ETF? Let us take a quick look at the fund and the near-term outlook on it to get a better idea of where it might be headed.
AMLP in FocusThe underlying Alerian MLP Infrastructure Index is capped, float-adjusted, capitalization-weighted composite of energy infrastructure Master Limited Partnerships that earn the majority of their cash flow from the transportation, storage, and processing of energy commodities. The product charges 85 bps in annual fees and yields 7.38% annually.
Why the Move?The recent surge in oil prices following escalating tensions in the Middle East region has aided the fund. The trajectory from here hinges on how long the disruption lasts and how much physical damage occurs to the energy infrastructure.
With some damage already done to the energy infrastructure in the Middle East, oil prices are less likely to return to pre-war levels. AMLP should benefit from this scenario. The fund also offers hefty current income—another plus for the segment.
More Gains Ahead?AMLP might continue its strong performance in the near term, with a positive weighted alpha of 11.18 (per Barchart.com), which hints at a rally.
2026-03-27 15:451mo ago
2026-03-27 11:261mo ago
Block Expands Square's Ecosystem: Will It Drive GPV Growth?
Key Takeaways Block's Square partners with Steak Escape to power drive-thru, kiosk and in-store ops across 23 sites.Square's platform enables faster service, real-time visibility and tighter cost control for franchises.Square sees rising QSR traction, with food & beverage GPV up 16% in Q4 2025 as more restaurants adopt it. Block’s (XYZ - Free Report) merchant-facing business, Square, has expanded its partnership with Steak Escape, a quick-service restaurant (“QSR”). Square’s unified commerce platform will empower Steak Escape’s drive-thru, kiosk and in-store experience across its 23 locations.
This arrangement with Square is a strategic fit for Steak Escape as the QSR platform seeks to expand its footprint. It will aid speed, multi-location consistency and seamless experience at every customer touchpoint. Square’s platform will reduce frictions in the multi-franchise model, providing real-time visibility and tighter cost control at every location.
Square’s integrated ecosystem of hardware, software and APIs makes it well-suited for Steak Escape’s expansion. Steak Escape has now incubated Square Register for in-store service, Square Handheld for drive-thru ordering, Square Kitchen Display System for integrated kitchen communication and Square Kiosk for self-service ordering. At the back-end, the Square for Franchises management solution is in operation. The brand is using Square's first-party integrations for loyalty, marketing and online ordering, alongside an integration with Restaurant365 for financial management.
Block’s Square platform provides sellers with point-of-sale (POS) solutions and business tools. Gross Payment Volume (GPV) remains a key metric, reflecting transaction volumes processed through Square’s ecosystem.
Square is gaining traction in the food & beverage space. Recently, The Pancake Parlour selected Square to streamline operations across 13 locations, while Cinnaholic reengaged the platform for its 85 outlets nationwide.
This momentum is reflected in performance. Square’s GPV from food & beverage sellers rose 16% year over year in the fourth quarter of 2025, driven by adoption among fine dining restaurants and breweries seeking operational efficiency and scalability.
How Are Block’s Competitors Faring?PayPal Holdings, Inc. (PYPL - Free Report) via its stablecoin, PayPal USD, is engaging with TCS Blockchain, a provider of transportation trade finance, to scale solutions for trucking and transportation companies (carriers). This collaboration enables more carriers to settle freight invoices faster and at lower cost, using blockchain-based digital assets. PayPal USD is available in 70 markets worldwide.
SoFi Technologies (SOFI - Free Report) partnered with Mastercard, allowing SoFiUSD as a settlement option across its global payments network. This will enable settling card-based transactions using SoFiUSD, aiding faster money movement for cross-border remittances and B2B money transfers. This highlights the usage of digital currencies on a global scale.
XYZ’s Price Performance, Valuation & EstimatesShares of Block have declined 9.9% in the past three months, outperforming the broader industry but underperforming the S&P 500 Index.
Image Source: Zacks Investment Research
In terms of forward 12-month P/E, XYZ stock is trading at 15.63X, which is at a significant discount to the Zacks Internet Software industry’s 26.22X.
Image Source: Zacks Investment Research
Block’s estimate revisions reflect a positive trend. The Zacks Consensus Estimate for full-year 2026 EPS has been revised northward 7.5% over the past month. It indicates a significant increase year over year.
Image Source: Zacks Investment Research
Block currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
2026-03-27 15:451mo ago
2026-03-27 11:281mo ago
AtaiBeckley awarded ‘Buy' rating in initial coverage from Deutsche Bank analysts
Deutsche Bank has initiated coverage on AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) assigning a 'Buy' rating and setting a price target of $12, implying potential upside of around 320% from current levels.
In a note to clients, analysts highlighted the company’s position in the emerging field of psychedelic medicine for mental health.
“Recently, several psychedelic companies have emerged as bona fide drug developers, attracting attention from healthcare and biotech investors who usually invest in conventional therapeutics,” they wrote. “We count ATAI among these trailblazers and believe it will become a leader in the nascent field of psychedelic medicine for mental health conditions.”
The firm cited AtaiBeckley’s lead programs, BPL-003 and VLS-01, which are being developed for treatment-resistant depression, an area with high unmet need.
The analysts noted that “with rapid-acting and potentially durable effects, BPL-003, followed by VLS-01, can leverage the existing Spravato commercial model in treatment-resistant depression, while displacing both market leader Spravato and first-generation, long-acting psychedelics.”
Deutsche Bank also noted that AtaiBeckley’s third program, EMP-01 for seasonal affective disorder, describing it as “akin to a call option.” The analysts wrote that their risk-adjusted discounted cash flow model suggests the shares are “materially undervalued, with approximately 3.5x upside versus approximately 70% downside in our base-case valuation.”
Phase 2 data for VLS-01 and Phase 2a Part 4 data for BPL-003, intended as an adjunct to SSRIs, are expected in the second half of 2026 and fourth quarter 2026, respectively, which Deutsche Bank noted could provide near-term catalysts for the stock.
2026-03-27 15:451mo ago
2026-03-27 11:291mo ago
Cybersecurity stocks fall on report Anthropic is testing a powerful new model
Cybersecurity stocks slumped on Friday following a report that Anthropic is testing a powerful new artificial intelligence model that is more advanced in cyber capabilities and also presents potential security risks.
Fortune first reported the news on Thursday, citing information from a publicly accessible draft blog post. According to the report, the new Mythos model is being touted as Anthropic's most powerful yet. However, the company is planning a slow rollout due to potential cybersecurity implications.
Anthropic did not immediately respond to CNBC's request for comment.
Cybersecurity stocks slumped on the news, as the iShares Cybersecurity ETF lost 3%, while market leaders CrowdStrike and Palo Alto Networks dropped 7%. Zscaler and SentinelOne tumbled over 8%. Tenable plummeted nearly 11%, while Okta and Netskope fell more than 6% each.
This isn't a new phenomenon for the sector that's fallen prey to AI disruption fears.
Last month, cyber stocks fell after Anthropic announced a new code-scanning security tool to Claude. The broader software space is also feeling the pressure from tech innovation.
The rise of AI and autonomous agents is shifting the threat landscape, putting pressure on cybersecurity companies to keep up with more sophisticated attacks and tools that make hacking easier.
Anthropic said in November that a state-sponsored group in China utilized Claude to automate a cyberattack.
Read the full Fortune article here.
watch now
Read more CNBC tech newsMeta's court defeats add to Zuckerberg's recent woes, represent 'watershed event' for social mediaMeet Figure AI: The company behind the humanoid robot hosted by Melania TrumpA Google AI breakthrough is pressuring memory chip stocks from Samsung to MicronElon Musk calls for Delaware judge to recuse herself in lawsuits, alleging bias
2026-03-27 15:451mo ago
2026-03-27 11:301mo ago
Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual Conference
Presentation will Cover Recent Corporate Milestones Including Securing Agreement with NIAID
SAN ANTONIO, TX / ACCESS Newswire / March 27, 2026 / Tivic Health® Systems, Inc. (Nasdaq:TIVC), a clinical-stage immunotherapeutics company, today announced that its newly appointed Chief Executive Officer, Michael K Handley, will deliver a corporate update at the Emerging Growth Virtual Conference taking place April 1-2, 2026.
During the virtual conference, Mr. Handley will highlight key milestones, including the company's recent agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to sponsor and conduct a preclinical study evaluating Entolimod™ for gastrointestinal acute radiation syndrome (GI-ARS). If the data of this study demonstrates efficacy, then NIAID may support future studies for the GI-ARS condition using Entolimod.
WHO: Michael K Handley, Chief Executive Officer
WHERE: April 1, 2026
WHEN: 2:55-3:05 PM Eastern Time
Attendees are encouraged to attend and/or listen to the presentation. Please register for the event at the below link.
If attendees cannot join the event live on the day of the conference, an archived webcast will also be made available on www.EmergingGrowth.com.
About the Emerging Growth
The Emerging Growth Virtual Conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner.
The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of individual and institutional investors, as well as investment advisors and analysts.
About Tivic
Tivic Health is developing biologics that activate innate immune pathways for cytoprotection and modulate immune responses in conditions driven by radiation, disease, and immune dysregulation. The company's lead candidate, Entolimod™ for acute radiation syndrome (ARS), has been extensively studied having demonstrated survival benefits and improved tissue recovery in animal models under the FDA's Animal Rule.
Entolimod™ is a novel Toll-like receptor 5 (TLR5) agonist that activates NF-κB signaling pathways to protect cells from damage and stimulate immune responses. Entolimod™ for ARS has received Fast Track and Orphan Drug designations from the U.S. Food and Drug Administration.
Tivic is also advancing Entolasta™, a next-generation TLR5 agonist designed for potential broader therapeutic applications, including oncology supportive care. Tivic's clinical pipeline includes potential treatments for neutropenia, which is most commonly caused by chemotherapy, and a state of T-cell dysfunction known as lymphocyte exhaustion.
Tivic's wholly owned subsidiary, Velocity Bioworks, is a full-service contract development manufacturing organization, (CDMO) offering biomanufacturing services to third-party biotech companies. Tivic also leverages Velocity Bioworks' manufacturing capabilities to advance its own drug pipeline with the expected benefits of lower costs, accelerated manufacturing outcomes and supply chain security. For more information, visit https://ir.tivichealth.com.
Forward-Looking Statements
This press release may contain "forward-looking statements" that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as "anticipate," "believe," "contemplate," "could," "estimate," "expect," "intend," "seek," "may," "might," "plan," "potential," "predict," "project," "target," "aim, "should," "will," "would," or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Tivic Health Systems Inc.'s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate, including as a result of the company's interactions with and guidance from the FDA and other regulatory authorities; the continued interest of BARDA and other U.S. government agencies in Entolimod; the ability of the company to achieve the expected benefits from the acquisition of development and manufacturing assets within expected time frames or at all; changes to the company's relationship with its partners; expectations regarding the potential benefits of the leadership transition; failure to obtain FDA or similar clearances or approvals and noncompliance with FDA or similar regulations, including related to the Animal Rule; the company's future development of Entolimod or Entolasta; changes to the company's business strategy; timing and success of pre-clinical and clinical trials and study results; regulatory requirements and pathways for approval; the company's ability to successfully commercialize its product candidates in the future; changes in the markets and industries in which the company does business; consummation of any strategic transactions; the company's need for, and ability to secure when needed, additional working capital; the company's ability to maintain its Nasdaq listing; and changes in tariffs, inflation, legal, regulatory, political and economic risks. Accordingly, you are cautioned not to place undue reliance on such forward-looking statements. For a discussion of risks and uncertainties relevant to the company, and other important factors, see Tivic Health's filings with the SEC, including, its Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 21, 2025, under the heading "Risk Factors", as well as the company's subsequent filings with the SEC. Forward-looking statements contained in this press release are made as of this date, and the company undertakes no duty to update such information except as required by applicable law.
Netflix (NFLX) is raising prices for all tiers of its streaming service, a headline that led several analysts to raise price targets on the stock. Marley Kayden takes a closer look at the analyst moves and why some see a guidance boost for the streaming giant.
2026-03-27 15:451mo ago
2026-03-27 11:311mo ago
RCL Targets $2T Vacation Market: How Big Is the Opportunity?
Key Takeaways Royal Caribbean booked about two-thirds of 2026 inventory at higher rates, boosting visibility.Royal Caribbean plans to expand into river cruising to broaden revenue streams.Royal Caribbean expects double-digit 2026 revenue growth and EPS of $17.70-$18.10. Royal Caribbean Cruises Ltd. (RCL - Free Report) is entering an important phase of strategic expansion as it looks to capture a larger share of the more than $2 trillion global vacation market. The company’s approach reflects a shift beyond traditional cruising toward building an integrated vacation ecosystem, supported by strong demand trends, product innovation and increasing digital engagement.
Royal Caribbean exited 2025 on a strong footing, with revenues nearing $18 billion and adjusted earnings growing 33% year over year. This performance was driven by solid pricing, healthy demand and continued cost discipline. Momentum has extended into 2026, with booking activity reaching record levels. Management indicated that approximately two-thirds of inventory is already booked at higher rates, providing a solid base for revenue visibility and yield optimization.
The next phase of growth is anchored in expanding the company’s vacation platform across multiple channels. A key initiative is the expansion into river cruising, where Royal Caribbean plans to significantly scale its fleet over time. Early booking trends suggest strong interest, particularly from repeat customers, indicating the company’s ability to leverage its existing customer base to drive incremental demand and broaden its revenue streams.
At the same time, Royal Caribbean continues to invest in differentiated experiences across its core business. This includes the rollout of new ships, expansion of private destinations and enhancements to its loyalty ecosystem. These initiatives are designed to strengthen pricing power, increase onboard spending and deepen customer engagement, reinforcing the company’s positioning within the broader vacation market.
Looking ahead, management expects double-digit revenue growth in 2026, supported by moderate capacity expansion and continued yield improvement. Adjusted earnings per share are projected in the range of $17.70 to $18.10, reflecting sustained profitability momentum. While industry capacity growth, particularly in key regions like the Caribbean, remains a variable, current demand trends and pricing dynamics suggest a stable operating environment.
How RCL Stacks Up to CompetitorsCompared with peers like Carnival Corporation & plc (CCL - Free Report) and Norwegian Cruise Line Holdings Ltd. (NCLH - Free Report) , Royal Caribbean appears to be operating from a position of relative strength, particularly in demand trends and pricing execution.
Carnival has highlighted strong booking momentum and improving profitability, supported by cost discipline and efforts to enhance its value proposition. However, its strategy remains largely focused on optimizing its core cruise business, with a continued emphasis on balance sheet repair and margin recovery.
In contrast, Norwegian Cruise is undergoing a transition phase focused on improving execution and aligning its commercial strategy with deployment. As outlined in its latest earnings call, execution gaps — particularly around pricing, itinerary planning and revenue management — have weighed on near-term yield performance, with full-year net yields expected to remain approximately flat.
Royal Caribbean’s strategy stands out in its broader push to expand the total addressable market through new product categories and destination-led offerings. While CCL and NCLH remain primarily focused on operational execution and near-term performance stabilization, RCL is simultaneously advancing long-term growth initiatives, including private destinations and adjacent vacation formats, aimed at deepening customer engagement and driving incremental spend. Although execution and industry capacity trends remain key variables, Royal Caribbean’s efforts to extend beyond traditional cruising could support sustained demand and enhance its ability to capture a larger share of the global vacation market over time.
RCL’s Price Performance, Valuation & EstimatesShares of Royal Caribbean have gained 32% in the past year compared with the industry’s 10% growth.
RCL Stock’s One-Year Price Performance
Image Source: Zacks Investment Research
From a valuation standpoint, RCL trades at a forward price-to-earnings ratio of 14.66, below the industry’s average of 15.23.
RCL’s P/E Ratio (Forward 12-Month) vs. Industry
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for RCL’s 2026 earnings implies a year-over-year uptick of 15.7%. The EPS estimates for 2026 have increased in the past 60 days.
EPS Trend of RCL Stock
Image Source: Zacks Investment Research
RCL’s Zacks RankRCL stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
2026-03-27 15:451mo ago
2026-03-27 11:311mo ago
Bitfarms Gears Up to Report Q4 Earnings: What's in the Offing?
Key Takeaways BITF is set to report Q4 results with revenues seen rising 6.17% YoY.Bitfarms faces pressure from high capex, debt growth and ongoing HPC/AI investments.BITF's impairments, restructuring and operational exits likely hurt quarterly performance. Bitfarms Ltd. (BITF - Free Report) is slated to release its fourth-quarter 2025 results on March 31.
The Zacks Consensus Estimate for fourth-quarter revenues is pegged at $59.63 million, reflecting mid-single-digit growth of 6.17% year over year.
The consensus mark for the bottom-line loss is currently pegged at 4 cents per share, narrowed by 1 cent over the past 30 days. This represents a sharp year-over-year deterioration from earnings of 3 cents per share.
Bitfarms’ earnings performance has been inconsistent in the trailing four quarters, but it has still delivered an average positive surprise of 18.75%.
Let us see how things are shaping up for the upcoming announcement.
Key Factors to Note Ahead of BITF’s Q4 ResultsBitfarms continues to struggle with weak profitability, as seen in its third-quarter 2025 results, which showed a gross loss of $2.9 million, an operating loss of $29 million and a net loss of $46 million. These losses were mainly due to high depreciation, impairment charges and rising operating expenses linked to infrastructure expansion. Although revenues improved, heavy cost burdens and ongoing investments in HPC/AI limited earnings growth. As cost pressures and spending remain high, continued losses and weak profitability are expected to have hurt Bitfarms’ performance in the quarter under review.
Bitfarms’ expansion into HPC/AI infrastructure has led to higher capital spending and increased debt. The company issued $588 million in convertible notes, expanded its credit facility and committed more than $128 million to data center development, along with additional project financing and acquisitions. While these moves support long-term growth, they also raise financial obligations and potential dilution risks. With substantial cash outflows directed toward long-term projects rather than immediate revenue generation, financial flexibility remains constrained. Therefore, higher capex and rising debt levels are likely to have pressured Bitfarms’ financial performance in the fourth quarter of 2025.
Bitfarms has been impacted by asset impairments and the exit of underperforming operations, particularly in Argentina and Paraguay. The company recorded significant impairment charges, including $9 million from continuing operations and approximately $34 million related to discontinued operations, primarily driven by the shutdown of its Argentina facility following a power supply halt and the classification of Paraguay assets as held for sale. These actions reflect operational disruptions and asset write-downs, reducing overall earnings visibility. With restructuring effects likely extending into subsequent periods, these impairments and discontinued operations are expected to have affected performance in the to-be-reported quarter.
However, Bitfarms’ extensive and strategically located power portfolio remains a core competitive strength, comprising 2.1 GW of capacity across North America, including 341 MW operational, 440 MW secured growth and 1,360 MW under application. Its assets are concentrated in high-demand regions like Pennsylvania, Quebec and Washington, where power supply is limited, and demand is strong, helping to support better pricing and efficient operations. This strong position likely helped Bitfarms benefit from rising AI-related demand and secure better opportunities, and is expected to have strengthened revenue visibility and margin potential in the fourth quarter of 2025.
What Our Model Says About BITF StockOur proven model does not conclusively predict an earnings beat for Bitfarms this time around. Per the Zacks model, the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. However, this is not the case here, as you can see below.
Bitfarms currently has an Earnings ESP of +100.00% and a Zacks Rank #4 (Sell). You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Stocks to ConsiderHere are some companies worth considering, as our model shows that these have the right combination of elements to beat earnings in their upcoming releases:
FactSet Research (FDS - Free Report) currently has an Earnings ESP of +1.67% and carries a Zacks Rank #2. FDS shares have declined 32.4% year to date. FDS is set to report its second-quarter fiscal 2026 results on March 31. You can see the complete list of today’s Zacks #1 Rank stocks here.
JPMorgan Chase & Co. (JPM - Free Report) has an Earnings ESP of +1.64% and carries a Zacks Rank #2 at present. JPM shares have fallen 9.5% year to date. JPM is set to report its first-quarter 2026 results on April 14.
Morgan Stanley (MS - Free Report) presently has an Earnings ESP of +15.41% and a Zacks Rank #2. MS shares have dropped 8% year to date. MS is slated to report its first-quarter 2026 results on April 15.
2026-03-27 15:451mo ago
2026-03-27 11:311mo ago
3 Momentum Anomaly Stocks to Buy as Mixed Signals Cloud Iran War End
Key Takeaways Micron stock surged 289.9% in a year but dropped 20% in the past week amid volatility.Credo gained 127.3% over the year, despite a 9.9% dip, driven by AI and cloud demand.Vermilion rose 61.1% annually but slipped 7.8% recently, with exposure to global commodity prices. The broader U.S. equity markets witnessed intense volatility over the past few days, as mixed signals emanated from the power corridors of Washington. While President Trump extended the deadline to initiate a deadly attack on Iran’s energy infrastructure to April 6, the Iranian government indicated that they had no intention of brokering any truce deal with the United States, even if its leaders are reportedly reviewing an American proposal to end the month-long war. Various media reports suggested that the Pentagon is also considering amplifying its military presence in the region to seek a resolution to this impasse.
The uncertainty has affected the global energy market, with crude oil prices remaining highly volatile. Although negotiations are continuing in the backdrop, an amicable solution appears to be very fragile. Amid the vagaries of the market, investors often seek to employ time-tested winning strategies to fetch sustained profits. One of the most successful game plans to beat the blues is to bet on momentum stocks, like Micron Technology, Inc. (MU - Free Report) , Credo Technology Group Holding Ltd (CRDO - Free Report) and Vermilion Energy Inc. (VET - Free Report) when value or growth investing fails to generate the desired profits.
This approach primarily tends to follow the adage, “the trend is your friend.” At its core, momentum investing is “buying high and selling higher.” It is based on the idea that once a stock establishes a trend, it is more likely to continue in that direction because of the momentum that is already behind it. Momentum investing is a way to profit from the general human tendency to extrapolate current trends into the future. It is based on that gap in time before the mean reversion occurs, i.e., before prices become rational again.
Momentum strategies have been known to be alpha-generative over a long period and across market stages. Therefore, this strategy is quite tricky to implement, as detecting these trends is not easy. Here, we have created a strategy to help investors get in on these fast movers and rake in handsome gains. Our screen will help you benefit from long-term price momentum and a short-term pullback in price.
Screening Parameters for Momentum Anomaly StocksPercentage Change in Price (52 Weeks) = Top #50: This selects the top 50 stocks with the best percentage price change over the last 52 weeks. This parameter ensures we get the best stocks that have appreciated steadily over the past year.
Percentage Change in Price (1 Week) = Bottom #10: From the above 50 stocks, we then choose those that are also among the 10 worst performers over a short one-week period. This parameter picks the ones that have witnessed a short-term pullback in price.
Zacks Rank #1: Stocks sporting a Zacks Rank #1 (Strong Buy) have a proven history of outperformance irrespective of the market conditions. You can see the complete list of today’s Zacks #1 Rank stocks here.
Momentum Style Score of B or Better: A top Momentum Style Score knocks out a lot of the screening process, as it takes into account several factors that include volume change and performance relative to its peers. It indicates when the timing is best to grab a stock and take advantage of its momentum with the highest probability of success. Stocks with a Momentum Score of A or B, when combined with a Zacks Rank #1 or 2 (Buy), handily outperform other stocks.
Current Price Greater Than $5: The stocks must all be trading at a minimum of $5.
Market Capitalization = Top #3000: We have chosen stocks that are among the top 3000 in terms of market value to ensure the stability of price.
Average 20-Day Volume Greater Than 100,000: A substantial trading volume ensures that these stocks are easily tradable.
Here are three of the eight stocks that made it through this screen:
Idaho-based Micron has established itself as one of the leading worldwide providers of semiconductor memory solutions. Micron manufactures and markets high-performance memory and storage technologies, including Dynamic Random Access Memory, NAND flash memory, NOR Flash, 3D XPoint memory and other technologies. Its solutions are used in leading-edge computing, consumer, networking and mobile products.
The stock has jumped a whopping 289.9% in the past year but declined 20% in the past week. Micron has a Momentum Score of A.
Based in Grand Cayman, the Cayman Islands, Credo provides various high-speed connectivity solutions for optical and electrical Ethernet and PCIe applications in the United States, Taiwan, Mainland China, Hong Kong, and internationally. Its products enable faster, more reliable, more energy-efficient, and scalable solutions that support the ever-expanding demands of AI, cloud computing, and hyperscale networks.
The stock has soared 127.3% in the past year but lost 9.9% in the past week. Credo has a Momentum Score of A.
Headquartered in Calgary, Canada, Vermilion engages in the exploration and development of petroleum and natural gas and optimization of producing properties in North America, Europe, and Australia. Its diversified portfolio delivers free cash flow through direct exposure to global commodity prices and enhanced capital allocation optionality.
The stock has surged 61.1% in the past year but lost 7.8% in the past week. Vermilion has a Momentum Score of B.
Zacks' 7 Best Strong Buy Stocks (New Research Report) Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.
Click Here, It's Really Free
Published in artificial-intelligence biofuels iot semiconductor tech-stocks
2026-03-27 15:451mo ago
2026-03-27 11:311mo ago
Noodles & Company closed dozens of restaurants last year. Here's why the stock price is soaring in 2026
As part of a strategic move to optimize its store footprint, Noodles & Company closed 33 company-owned restaurants in 2025. In January, the chain said it would close dozens more stores this year.
However, despite the shrinking restaurant count, sales have grown.
The fast-casual eatery held its fourth-quarter and full-year 2025 earnings call on Wednesday, March 25. It reported that comparable store sales increased 6.6% in the final quarter of 2025. Sales growth and traffic are also up as of early 2026.
Following the strong earnings report, shares of Noodles & Company (Nasdaq: NDLS) soared over 50% on Thursday.
Subscribe to the Daily newsletter.Fast Company's trending stories delivered to you every day
The stock is up almost 60% year to date as of premarket trading on Friday. That’s a significant contrast to the broader Nasdaq Composite, which is down 7.78% for 2026 so far.
How store closures have helped same-store sales Despite having closed more than 30 stores in 2025, Noodles & Company reported system-wide comparable store sales growth of nearly 7% in the fourth quarter of 2025.
On Wednesday’s earnings call, CEO Joe Christina told investors that the restaurant closures “resulted in a material transfer of sales to nearby locations . . . which also favorably impacted margins.”
Lawsuit Alleges IPO Documents Concealed Impending "Corporate Pivot" and Executive Turmoil; Firm Reminds Investors of May 18 Lead Plaintiff Deadline SAN FRANCISCO, March 27, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is notifying investors that a securities class action lawsuit has been filed against Gemini Space Station, Inc. (NASDAQ: GEMI) and its top executives, including founders Cameron and Tyler Winklevoss. The litigation follows a series of disclosures that have caused the company's stock to trade more than 75% below its initial public offering (IPO) price.